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ABSTRACT 
A vast quantity of literature exists examining the relationship 
between Insulin Dependent Diabetes Mellitus (IDDM) and eating 
disordered symptomatology, however little is known about such 
behaviour among Non-insulin Dependent Diabetes Mellitus (NIDDM) 
populations. Obesity has been identified as a risk factor in the 
development of NIDDM and the treatment of choice for obese patients 
with type II diabetes is dieting to promote weight loss. In addition, there 
appears to be an association between dieting and binge eating. Such 
factors considered, it seems imperative to address the issue of eating 
disordered behaviour in NIDDM populations. 
The few studies conducted in this area indicate that eating 
disordered behaviour may be a problem for this population. However it 
is not known whether this finding translates to clinic populations. 
Furthermore, past studies have also found high rates of depressive 
symptomatology among diabetic populations. 
The present study aimed to assess the prevalence and severity of 
binge eating and depressive symptomatology and possible associations 
between the two, in a clinic population of women with NIDDM. Of 
further interest was the occurrence of dieting behaviour and the 
relationship between binge eating, depressive symptomatology, insulin-
manipulation, obesity, glycemic control, duration of diabetes and 
medical illnesses. 
Although both binge eating and depressive symptomatology were 
significantly more prevalent and severe in the diabetic population, the 
rate of binge eating was not as high as that found in past research. 
Binge eating and depressive symptomatology were also associated. 
Furthermore, although dieting behaviour per se was not significantly 
more prevalent, the diabetic group indicated significant dissatisfaction 
with their current weight and body shape. In addition, both binge 
eating and dieting were associated with poorer glycemic control. The 
prevalence of insulin manipulation among NIDDM women was 
comparable to many studies using IDDM populations. Reasons for 
these findings are discussed in light of the existing literature and 




A condition in which there is either (i) a production in the body of two 
abnormal acids, or (ii) a diminution in the alkali reserve of the blood. 
Autoimmune Attack 
The process whereby an individual develops antibodies which attack 
her I his own tissues. 
Beta Cell 
Cells in the pancreatic islets. 
Glycemia 
The presence of glucose in the blood. 
Glycosurla 
The spillage of excess glucose into the urine, an event common in 
uncontrolled diabetes mellitus. 
Hepatic 
Involving/ pertaining to the liver. 
Hyperglycemia 
Increase in blood sugar. 
Hypoglycemia 
Deficiency of blood sugar. 
Insulinopenia 
Relative or absolute lack of insulin. 
Islet Cells 
ix 
Groups of specialised cells throughout the pancreas that produce three 
hormones; insulin, glucagon and somatostin. 
Ketoacidosis 
A syndrome seen in poorly controlled diabetes mellitus with 'starvation 
admist plenty'; despite hyperglycemia, insulin deficiency makes the 
excess glucose unavailable to the cells and they must rely upon lipid 
metabolites (ketone bodies) resulting from incomplete lipid metabolism 
for energy. 
Ketosis 
A condition in which an excessive amount of ketones are produced by 
the body and these accumulate in the blood stream. 
Macrovascular disease 
Vascular disease of the large vessels, leading to stroke, heart attack and 
eri heral vascular disease. 
Neuropathy 
A generic term referring to a disorder of the peripheral nerves. 
Nephropathy 
From small blood vessel damage, clinically manifested primarily in the 
kidney. 
Polydipsia 
A general term for excessive drinking or thirst. 
Polyphagia 
A general term for excessive eating. 
Polyuria 
A general term for excessive frequency/ urge of urination. 
Sulfonylureas 
Sulfonylurea drugs are oral hypoglycemic agents used in the 
management of patients with diabetes mellitus. 




1.1 General Introduction 
A number of psychological and psychiatric symptoms and 
syndromes have been associated with diabetes mellitus, including 
anxiety, mood, personality and eating disorders. It is beyond the scope 
of the present study to review all of this literature. As such, the focus of 
this study is limited to (subclinical} eating disorders/behaviour and 
depression. A vast amount of literature exists examining the 
relationship between Insulin Dependent Diabetes Mellitus (IDDM; 
defined below} and eating disorders. The literature suggests that eating 
disordered behaviour may develop in IDDM populations, and subclinical 
eating disorders, such as binge eating, may be more prevalent among 
this population than in controls or the general population. 
Intentional insulin manipulation, for weight control or weight 
loss, also appears to occur at a rate worthy of concern. Such behaviour 
is worrisome for many reasons, particularly as it compromises glycemic 
control, and therefore the physical and psychological well-being of the 
individuals involved. 
Depression also occurs at a rate higher than that of the general 
population in both IDDM and Non-Insulin Dependent Diabetes Mellitus 
(NIDDM; defined below} samples, however the cause of this is yet 
unknown. 
Little is known about the occurrence of eating disordered 
behaviour amongst NIDDM samples. The few systematic studies that 
have been conducted indicate that such behaviour, for example binge 
eating, may also be a problem for this population. However many of 
these studies incur a number of methodological flaws and sampling 
biases, limiting the validity of their findings. 
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The focus of the present study is eating disordered behaviour 
(primarily, binge eating) and depressive symptomatology and, as related 
to illness duration, glycemic control, and obesity, in a New Zealand 
clinic based population of women with NIDDM. 
1.2 Literature Review 
1.2.1 Background to Diabetes mellitus 
Description 
Diabetes mellitus is a chronic endocrine syndrome characterised 
by inappropriate hyperglycemia* caused from an absolute or relative 
deficiency of insulin production by the pancreas, causing disturbed 
carbohydrate metabolism with hypoglycemia and glycosuria. Secondary 
changes are prone to occur in the metabolism of protein and fat, the 
latter leading to ketosis and acidosis (Lishman, 1987), which can 
consequently cause damage to many parts of the body. Some of the 
long-term effects of diabetes, especially if left untreated include 
increased chance of heart attack, stroke, blindness, kidney disorders, 
impotence and numbness of the feet (Moore, 1995). 
The classic symptoms of diabetes include polydipsia, polyuria, 
sudden weight loss, headaches, drowsiness, nausea and vomiting, 
stomach pain, sweet breath, blurred vision and thrush. However, some 
individuals may experience none of these symptoms (Moore, 1995). 
Diagnosis and Classification 
The National Diabetes Data Group (NDDG) (1987) classification 
has provided a framework for both diagnosis and classification of 
diabetes (see Table 1). This gives three independent criteria for 
diagnosing diabetes mellitus, pending further classification in type. 
* Words in italics are defined in the glossary, presented at the beginning. 
2 
Table 1 
Crl.terl.a for diagnosis of Diabetes MelUtus 
These are diagnostic criteria for diabetes mellitus in the non-pregnant 
adult. Any one of the following is sufficient to make the diagnosis. 
1. A random plasma glucose level > 200 mg/ dL together with classic 
signs and symptoms, including polydipsia, polyuria, polyphagia, and 
weight loss. 
2. A fasting plasma glucose level > 140 mg/ dL on two measurements, 
independent of symptoms. 
3. A fasting plasma glucose level >140 mg/dL, but an abnormal 
response to two 75-gram oral glucose intolerance tests as manifested by 
a 2-hour plasma glucose > 200 mg/ dL with an intervening value > 200 
mf!,,/ dL. 
The historic classification of juvenile-onset versus adult-onset 
diabetes eroded with the realisation that both forms of diabetes may 
occur in any age group (Ratner, 1992). The newer classification is an 
attempt to define the specific diseases according to aetiologic 
mechanism. The disorder once described as juvenile-onset diabetes is 
now more appropriately named type I diabetes, or insulin dependent 
diabetes mellitus (IDDM), and adult-onset type II or non-insulin 
dependent diabetes mellitus (NIDDM). Other types of diabetes mellitus 
include impaired glucose intolerance and gestational diabetes mellitus. 
The distinguishing features of IDDM include patients of any age, 
usually thin and usually have abrupt signs and symptoms with 
insulinopenia before age 40 years. As the pancreas has stopped 
producing insulin, these patients often are dependent upon insulin to 
prevent ketoacidosis and to sustain life. 
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NIDDM patients are typically older than 40 years at diagnosis, 
obese and have relatively few classic symptoms. Although not 
dependent upon exogenous insulin for survival, they may require it for 
hyperglycemia that persists in spite of other therapy (NDDG, 1987). 
Tablets are frequently used to improve insulin production and 
operation. Diet and exercise habits and lose of weight may also improve 
metabolic control (Moore, 1995). NIDDM (type II) increases 
considerably with age, with a systemic increase in prevalence at each 
decade over the sixth (Ratner, 1992). (See Table 2 for a comparison and 
summary of IDDM and NIDDM). 
Two major problems emerge from this classification system. 
First, the terms IDDM and NIDDM imply that the two types differ 
depending on whether insulin is used to control diabetes. This is not 
the case, as approximately 50% of all individuals with NIDDM are 
treated with insulin (Martin & Quint, 1985, cited in Ratner, 1992). 
Second, the descriptions of type I and type II disease in no way suggest 




Summary and Comparison of IDDM and NIDDM 
IDDM NIDDM 
Clinical features 
Age of Onset Usually <30 years, but Usually >35 years, but 
can occur at any ru!e can occur at any ru!e 
Onset Often rapid Insidious 
Weight Non obese, thin Often obese, may be 
normal 
Symptoms Polydipsia, polyuria, Frequently not 
polyphagia recognised or less acute 
in presentation 
Acute Complications Insulin reactions and Usually none 
ketoacidosis 
Intermediate Failure of growth and Problems during 
Complications development, problems pregnancy 
during pregnancy 
Longterm Small blood vessel Large blood vessel 
Complications problems in eyes, problems in heart, brain 
kidneys, nerves; large and feet; small blood 
blood vessel problems vessel problems in eyes, 
in the heart, brain and feet, nerves and kidneys 
feet 
Epidemiology 
Occurrence 10-20% of all diabetics 80-90% of all diabetics 
Sex Ratio Slight male Greater prevalence in 
predominance females 
Seasonal Variation Present Unknown 
Genetics 
Concordance in <50% >90% 
identical twins 
Environmental Virus, toxins, Obesity, nutrition 
factors autoimmune stimulus 
Diabetes Control 
Dietarv Manru!ement Essential Essential, may suffice 
Insulin Required for all Required for 20-30% 
Modified from Galloway et al. (1988). 
Epidemiology and Demographics 
Diabetes mellitus affects approximately 12 million individuals in 
the United States, and perhaps as many as 200 million worldwide 
(Ratner, 1992). In New Zealand 4-5% of people of European descent 
and 10-15% of individuals of Maori or Pacific Island descent have 
diabetes (IDDM and NIDDM combined). In addition, 7,500 new cases 
are diagnosed each year (Diabetes New Zealand, Inc, 1984). Of these, 
NIDDM patients account for approximately 90% of the United States 
cases. Perhaps what is most alarming however, is that approximately 
half of such cases may be undiagnosed (Ratner, 1992). 
In addition, minority populations have significantly higher relative 
rates of NIDDM when compared with an age-matched white population 
- for example, diabetes is two times more common in blacks, 2.5 times 
more common in Hispanics, and five times more common in Native 
Americans (Winter et al. 1987; Harris et al. 1987). Although obesity 
certainly contributes to these increased risks, black Americans are 
more likely to have diabetes even when adiposity and socio-economic 
status are controlled for (O'Brien et al. 1989). However, Cowie, Harris, 
Silverman, Johnson & Rust (1993) found that differences in the 
prevalence of NIDDM between African Americans and whites are 
partially, but not entirely explained by an increased prevalence of 
known risk factors in African Americans. 
Aetiology of lDDM 
It is known that type I, or IDDM, is the result of an autoimmune 
attack on the beta cell (Eisenbarth, Connelly & Soeldner, 1987; cited in 
Ratner, 1992). In addition, it has long been known that there is a 
genetic propensity for the occurrence of IDDM. The risk of IDDM in the 
general population ranges from 1 in 400 to 1 in 1000, whilst that risk 
substantially increases in the offspring of individuals with diabetes to 
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approximately 1 in 20 to 1 in 50 (Raffel & Rotter, 1985). Recent 
understanding of the genetics of IDDM is leading to research into the 
identification of markers of susceptibility for the disorder (Ratner, 
1992). 
It is also clear that not all individuals at genetic risk will develop 
IDDM. Convincing evidence that genetics are not sufficient for the 
development of the disease is the finding of a 50% discordance rate of 
IDDM between identical twins. This suggests that some trigger is 
necessary for the expression of this genetic propensity. Environmental 
triggers for the development of IDDM have long been suspected. In 
particular, it is quite evident that multiple viruses appear to trigger the 
subsequent immunologic response in genetically predisposed 
individuals who develop IDDM (Ratner, 1992). 
Aetiology of NIDDM 
NIDDM is a very distinct disorder when compared with IDDM. 
NIDDM is a heterogeneous disorder, characterised by variable plasma 
insulin levels associated with hyperglycemia and peripheral insulin 
resistance. Again, heredity plays a major role in its transmission (See 
Table 2). The offspring of patients with type II diabetes have a 15% 
chance of developing NIDDM and a 30% risk of developing impaired 
glucose tolerance (Raffel & Rotter, 1985). In addition, there is a 
greater than 90% concordance rate between monozygotic twins if one 
has type II diabetes, suggesting the primacy of the genetic defect in this 
form of disease. 
Currently, multiple theories exist to explain the defects observed 
in NIDDM and, in sum, clinical observations would suggest several 
phenomena at work (Ratner, 1992). Firstly, limitation in beta cell 
response to hyperglycemia appears to be a cornerstone of the 
pathophysiology of NIDDM. Regardless of the degree of peripheral 
7 
insulin resistance, if the islet cells have an unlimited capacity to secrete 
insulin, then sufficient insulin should be available to overcome any 
degree of resistance. However, it is apparent that the beta cell is unable 
to respond appropriately to a hyperglycemic challenge (Ratner, 1992). 
Morphological studies have revealed an approximate 50% reduction in 
beta cell mass in individuals with NIDDM as compared with controls, 
particularly when the degree of obesity is also taken into account 
(Klopell et al. 1985; cited in Ratner, 1992). This concept has been 
referred to as glucose toxicity. In essence, it has been found that beta 
cells chronically exposed to hyperglycemia become progressively less 
efficient in responding to subsequent glucose challenges. This is a 
reversible phenomenon in which normalisation of ambient glucose 
produces a dramatic improvement in insulin secretory response to a 
fixed glucose challenge (Leahy, 1990). 
A second hallmark of NIDDM is the presence of resistance to the 
biologic activity of insulin noted in both the liver and peripheral tissues, 
where regardless of circulating insulin levels, individuals with NIDDM 
have a continued hepatic glucose production that increases circulating 
glucose levels (Ratner, 1992). 
Risk Factors for NlDDM 
In addition to the known genetic and physiological factors 
outlined above, there are some individuals who are more at risk for 
developing NIDDM than others, including those who are overweight, 
over 40-45 years of age, those who had diabetes during pregnancy, 
giving birth to a large baby (which can be independent of diabetes 
during pregnancy), having a family history of diabetes, having high 
blood pressure, being of Maori, Pacific Island or Asian descent or being 
on medications which can induce diabetes (eg: steroids) (Moore, 1995). 
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Twenty percent above ideal body weight, corresponding to a Body 
Mass Index (BMI) of approximately 27 -28, has been defined as a health 
hazard (National Institutes of Health, 1985; cited in Wing, 1993).* 
Approximately 75% of patients with NIDDM are obese (usually 
associated with a BMI of greater than 30). Clinical studies suggest that 
obesity allows for increased expression of the genetic propensity 
(Ratner, 1992). Obesity is a major factor in the development and 
perpetuation of diabetes. Obesity is more common in women than in 
men and is particularly common among ethnic minority women (Cowie 
et al. 1993; Kuczmarski, Flegal, Campbell & Johnson, 1994; Pi-Sunyer, 
1994). Cowie et al. (1993) suggest that there may be an ethnic 
difference in metabolic adaptation to obesity. 
1.2.2 Diabetes Management 
Clinical measurement 
Implementation of clinical care for the individual with diabetes is 
now serving as the paradigm for a chronic-disease model of health care 
delivery. Involving the individual in his or her health care is the first 
step toward implementing preventative medicine and is revolutionising 
the concept of health care delivery (Ratner, 1992). 
Self-monitoring of blood glucose (SMOBG) technology allows for a 
realistic management of glycemi.a on an outpatient basis (Ratner, 1992). 
In addition, glycated haemoglobin determinations are an additional 
clinical laboratory assessment that have become invaluable in both 
research and clinical care. The most relevant application of glycated 
haemoglobin (for example HbA1*) is the assessment of long-term 
glycemic control. From a research perspective, it is an indispensable 
* Body Mass Index (BMI) is used as a measure of body fat and obesity. It is formulated 
using weight in kg divided by height in meters squared (Garrow & Webster, 1985). 
*HbA 1 is a biochemical test which provides an index of the average blood glucose level 
over a period of approximately 1-3 months (Rodin, Johnson, Garfinkel, Daneman & 
Kenshole, 1986-7). A value of below 10% is generally regarded as indicative of 
adequate glycemic control (Peveler & Fairburn, 1992). 
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parameter in relating glycemic control and long-term diabetic 
complications (Goldstein et al. 1987; cited in Ratner, 1992). Multiple 
methodologies with varying nonnative values exist for measuring 
glycated haemoglobin (Ratner, 1992). 
Treatment 
Despite rapid advances in medical research exploring the outer 
limits of molecular biology and immunology, pharmacologic intervention 
in individuals with diabetes has remained virtually unchanged over the 
last 20 years (Ratner, 1992). Interventions with diet, exercise, 
sulfonylureas, and insulin are different only in degree from those used 
in the 1950's. Diet appears to play a pivotal role in the treatment of this 
chronic disease. The main goal in treating diabetes is to restore the 
body's ability to produce or use carbohydrates (glucose) (Ratner, 1992). 
1.2.3 Medical and Psychological Associations 
Medical 
With adequate treatment of diabetes, good health can be 
maintained. However parts of the body which can be affected in the 
long term are the eyes, kidneys, heart and feet. Diabetes also increases 
the risks of male impotence, heart attack, stroke and birth defects. 
Good glycemic control is a major factor in the avoidance of such 
complications (Diabetes New Zealand, Inc. 1984; Lloyd, Matthews, Wing 
& Orchard, 1992). 
These problems may affect metabolic control directly, via the 
neuroendocrine and physiological effects of stress, or indirectly via poor 
self-care. Deteriorating metabolic control then may exert a negative 
reciprocal effect upon emotional, psychological, and interpersonal 
difficulties. This downward spiral can lead to life threatening crises, 
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such as hypoglycemic blackouts and coma, and may accelerate the 
complications of diabetes (Rubin & Peyrot, 1992). 
The association between medical complications and quality of life 
is supported by Lloyd et al. (1992), who found that those individuals 
who experienced macrovascular disease or neuropathy reported 
significantly poorer quality of life compared with those who were free 
from all complications, and quality of life significantly deteriorated 
according to the presence of multiple complications. 
Psychological/ Psychiatric 
Regardless of the growing recognition of the profound emotional 
and psychosocial impact of diabetes, the literature examining these 
areas is sparse. However a number of associated psychological 
complications, including mood, anxiety, eating, drug and alcohol, 
personality symptomatology and/ or disorders and low self-esteem, have 
been observed to occur more frequently in individuals with diabetes 
(Rodin, 1983; cited in Rodin, Johnson, Garfinkel, Daneman & Kenshole, 
1986-87). Weyerer, Hewer, Pfeifer-Kurda and Dilling (1989) conducted 
a community study and found that for both the diabetic population and 
individuals with other chronic medical conditions, although mainly 
mild, the prevalence of psychiatric disorders was significantly higher 
than among a healthy control group. 
In addition Popkin, Callies, Lentz, Colon and Sutherland (1988) 
found that 38 (51 %) of the patients with long-standing type I diabetes 
received one or more psychiatric diagnoses, including depression, 
anxiety and personality disorders. Interestingly, they found that none 
of these disorders were related to the duration of diabetes or the 
presence of various complications. Rubin and Peyrot (1992) believe that 
the prevalence of psychopathology appeared no higher among people 
with diabetes than among those with other chronic diseases. However 
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regardless of the prevalence or severity of these problems in the diabetic 
population at large, those individuals who do suffer from these 
problems are at special risk for reduced physical and emotional well-
being (Rubin and Peyrot, 1992). 
A literature review examining the association between diabetes 
and all of the above mentioned psychiatric diagnoses is beyond the 
scope of this research, and thus the remainder of this literature review 
will be limited to eating/ diet related and depressive symptomatology. 
Eating I diet related problems 
According to Heins and Beebe (1992), food is not only a source of 
nutrition, but it also holds both cultural and social significance. 
Society also encourages individuals to be thin and to diet to achieve this 
ideal (Moore, 1995; Stancin, Link & Reuter, 1989). While diet is 
recognised clinically as the cornerstone of diabetes therapy, especially 
in NIDDM, individuals with diabetes say that dietary compliance is the 
most difficult part of their treatment regimen. There are several 
possible reasons for this. 
One possible reason is the cultural and social factors addressed 
previously. In addition, diets prescribed for diabetics have the added 
challenge of overcoming an abnormal metabolic response to food. 
Secondly, the size, composition, and timing of meals must be designed 
to maximise insulin efficiency and promote as near normal energy 
metabolism as is possible. Thirdly, individuals with diabetes, especially 
obese women, are encouraged to focus on their food intake and are 
constantly being told by health professionals to look at what they eat 
and to keep a reasonable body weight. Finally, weight reduction 
improves glycemic control and thus lessens the risk of the many 
associated medical complications. 
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Consequently, as will be discussed further in this paper, recent 
research suggests that eating related disorders [anorexia nervosa, 
bulimia nervosa, and sub-clinical variants, such as binge eating 
(disorder)] may be somewhat more common in specific populations of 
individuals with diabetes than in the general population (Wing, Marcus, 
Epstein, Blair & Burton, 1989; Stancill et al. 1989; Rodin & Daneman, 
1992; Rodin, Craven, Littlefield, Murray & Daneman, 1991; Rodin, 
Daneman, Johnson, Kenshole & Garfinkel, 1985). 
The reasons for this association may be multiple: the alterations 
in body image, the sense of autonomy and identity, self-esteem, mood 
regulation, and family interactions may all be possible contributory 
factors (Heins & Beebe, 1992). In addition, as has been described, 
individuals with diabetes typically have poorer metabolic control. 
Subsequent eating disordered behaviour such as direct metabolic 
effects of binge eating, self-induced vomiting, laxative abuse and 
noncompliance with diabetes-prescribed medications, for example, 
intentional insulin omission, are all behaviours that have a potentially 
devastating effect on the often poor metabolism (Heins & Beebe, 1992; 
Rubin & Peyrot, 1992). Even subclinical eating disorders can interfere 
with glycemic control (Wing, Norwalk, Marcus, Koeske & Finegold, 
1986). 
Depressive symptomatology 
Lloyd et al. (1992) found that patients with medical complications 
such as macrovascular disease also reported greater depressive 
symptomatology, and that high scores on instruments measuring 
depressive symptomatology were also related to the presence of four or 
more complications. 
In a community study Weyerer et al. ( 1989) found that both those 
with diabetes and other chronic medical illnesses experienced a 
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significantly higher prevalence of depression. They noted that the high 
rate of depression in the diabetic population may partly be explained by 
an overlap of symptoms. A number of symptoms frequently experienced 
by individuals with depression such as weight loss, tiredness, 
weakness, fatigability, confusion, dizziness, impaired judgement, 
anxiety, trembling and emotional upset may also occur as a result of 
hyper- /hypoglycaemia. A limitation of this study however is that no 
distinction was made between IDDM and NIDDM patients, and further 
as it was a cross-sectional study, no causal links between psychiatric 
status and diabetes can be determined. 
Popkin et al. (1988) found a striking 24% lifetime prevalence rate 
of major depression, which could not be attributed to gender, age group, 
duration of illness, or the presence of various diabetic complications. It 
was proposed that this rate may be a function of the subtle changes in 
the vasculature of these patient's central nervous systems. The 
possible behavioural and cognitive sequelae of such changes have 
received little attention. The subjects used in this study however were 
all candidates for pancreas transplant, and therefore may have been at 
the more severe end of the diabetes spectrum. Therefore these results 
should be interpreted with caution as this population may not be 
representative of all diabetics in general. 
In further support of the association of affective illness and 
diabetes, Koranyi (1979) screened 2090 unselected psychiatric clinic 
cases, which revealed a rate of diabetes 2.3 times greater than would be 
expected based on population estimates. Likewise, a retrospective chart 
review of 203 manic-depressive patients found diabetes in 10% of the 
sample compared with the expected rate, derived from epidemiological 
surveys, of 2% (Lilliker, 1980). Both these studies however used biased 
samples as they were both psychiatric and clinic selected. This may 
therefore be more representative of the severe end of the diabetes 
14 
spectrum, rather than representative of diabetes in the general 
population. 
Swnmary 
Diabetes mellitus is a chronic endocrine syndrome which affects 
approximately 200 million people worldwide and, in New Zealand 
approximately 7,500 new cases are established each year. Diabetes 
results from either absolute or relative deficiency of insulin production 
by the pancreas, and can cause damage to the body. There are mai,y 
long-term effects of diabetes, especially if left untreated, including 
increased risk of stroke, blindness and kidney disease. 
There are two main types of diabetes, Type I (also called IDDM or 
juvenile onset) and Type II (NIDDM or maturity onset). These two types 
are distinguishable in many ways including factors such as age, onset, 
risk factors, aetiology, complications and genetic inheritance. There are 
also known risk factors for the development and maintenance of Type II 
diabetes including being overweight, over 40-45 years, having high 
blood pressure and being of ethnic descent (for example, Maori or 
Pacific Islander). 
A number of medical and psychological problems and 
complications may occur with diabetes. Medical complications include 
the long term effects mentioned above and many more, which may all 
have a substantial effect on overall quality of life. In addition, due to 
the emotional impact of diabetes, mood, anxiety, eating, drug and 
alcohol problems and low self ~esteem may often feature. Although 
inconclusive, it appears that eating and depressive symptomatology 
may be more prevalent in diabetic populations, and worthy of further 
investigation. Perhaps more importantly, regardless of the severity or 
prevalence of these problems in the diabetic population, individuals who 
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present with these problems are at risk for reduced physical and 
emotional well-being. 
1.2.4 Binge eating and diabetes 
What is binge eating? 
The definition of what constitutes a binge, and subsequently 
binge eating has changed since its original inclusion in the Diagnostic 
and Statistical Manual of Mental Disorders - Third Edition (DSM-III) 
(American Psychiatric Association (APA), 1980), where the definition 
was 'rapid consumption of a large amount of food in a discrete period of 
time, usually less than two hours'. In the DSM-III-Revised (DSM-III-R) 
(APA, 1987), the suggested 2-hour limit was dropped. 
The DSM-IV (APA, 1994) proposes a radical addition where a 
feeling of lack of control during the binge is also required (Beglin & 
Fairburn, 1992). This may be experienced either objectively and/or 
subjectively. An objective binge applies to the consumption of an 
unusually large amount of food over a short period of time, whilst a 
subjective binge occurs when an objectively small or normal amount of 
food is consumed, but the individual may have felt out of control when 
consuming it, or believed it to have violated some strict dietary rule 
(Bulik, 1994). Following an episode of binge eating, a sense of 
dysphoria is also experienced by many (Beglin & Fairburn, 1992), 
including feelings of sadness, guilt and depression. In some cases it is 
followed by, or interrupted by, self-induced vomiting which relieves 
gastric fullness and averts weight gain (Wardle, 1987). However, as 
highlighted by deZwaan and Mitchell (1992) the ending of an eating 
binge is not punctuated and thus many patients experience difficulties 
recalling and labelling binge eating episodes. 
There may be discrepancies between the lay and the technical 
uses of the term 'binge eating'. Beglin and Fairburn ( 1992) found that a 
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population of young women placed greater emphasis upon loss of 
control and somewhat less on the quantity of food eaten. The authors 
also suggest that there may be both regional and sub-cultural 
differences in the use of the term. As a result of the differences in the 
use of the word and concept of a 'binge', research in this area often 
lacks cohesiveness and comparability. Nevertheless, the consensus 
regarding the primary symptoms of binge eating are the consumption of 
an unusually large amount of food over a short period of time (objective 
binge), which is often accompanied with a sense of loss of control and 
subsequent fullness and dysphoria (Bulik, 1994; Beglin & Fairburn, 
1992). 
Dieting and Binge Eating 
There is considerable evidence that dieting and bingeing co-occur 
(Polivy & Herman, 1985; Herman & Polivy, 1990). Bingers, in short, 
tend to be dieters, as is shown by several researchers. For example, 
Loro and Orlean's (1981) population of obese bingers were all attending 
a weight loss clinic. 
In relation to the sequential nature of these two behaviours, 
Polivy and Herman (1985) propose that dieting precedes bingeing, and 
more specifically dieting increases the likelihood of subsequent 
bingeing, as is supported by both the clinical and experimental 
literatures. Herman and Polivy (1990) state however that as binge 
eating is a complex concept, and difficult to understand and explain, 
that the literature is not yet in a strong position to posit causes or 
mechanisms. In addition, although there appears to be an association 
between restrained eating and bingeing, to assert a clear causal link 
would be making some unwarranted assumptions. They conclude by 
stating that there is much empirical and conceptual work yet to be 
done. 
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A number of propositions exist which may explain why dieting 
increases the likelihood of bingeing. One of these is the physiological 
defence, where dieting produces weight loss, which in turn may create a 
state of chronic hunger. Binge eating might therefore represent the 
body's attempt to restore weight to a more biologically appropriate level, 
and appears to be a psychobiological adaptation to sub-optimal weight 
and food deprivation (restraint theory). This biologically appropriate 
level may not however correspond to the cultural or personal 
aspirations of the dieter (Polivy & Herman, 1985). Thus, Wardle (1987} 
states that compulsive eating is best understood in terms of a conflict 
between a biologically derived drive for food and a culturally derived 
drive for thinness. 
In addition to this argument, one concept which has been central 
to the development of work on dietary restraint is Nisbett's (1972) 
suggestion that individuals have a 'set point' for weight which is 
homeostatically defended. The set point may be operating above or 
below the levels of weight which are deemed appropriate by cultural and 
medical ideals. The notion of a homeostatically defended set point has 
come up against considerable criticism on good empirical grounds, and 
few people would now claim that there is a specific and stable weight for 
an individual (Wardle, 1987). However, the idea that dietary restraint 
results in biologically derived adaptations tending to facilitate weight 
gain is logically distinct from the notion of set point, and this now has 
considerable support (Wardle, 1987). 
Further research suggests that role of cognitions and situational 
pressures are crucial to the instigation of binge eating and dieting itself. 
This position should not be interpreted as a rejection of the 
physiological factors identified above in the control of eating, rather 
suggests a multi-componential view. The ways in which the 
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physiological and non-physiological interact to affect eating are largely 
unclear at present (Polivy & Herman, 1985). 
Polivy & Herman (1985) believe that non-physiological aspects, 
namely cognitive factors, may be central determinants of intake on any 
given occasion as the overeating or counterregulation of restrained 
eaters seems to be critically mediated by cognitions. For example, as 
long as dieter's believe themselves to be 'in control', with their diets 
intact, they eat frugally, but when they believe that their diets have 
been violated or that they are no longer capable of controlling their 
intake, they overeat or even binge. 
A closely related construct is the 'abstinence violation effect', in 
which a minor violation of a strict rule results in a cognitive appraisal of 
failure which itself heralds a motivational collapse (Marlatt & Gordon, 
1980). In the case of a restrained eater this might be seen when she 
decides that eating two biscuits with coffee has ruined her diet and so 
she might as well abandon the whole enterprise and finish the packet 
(Ward, Hudson & Bulik, 1993; Wardle, 1987; Wilson, 1993). Such rigid 
distinctions contribute to the dieter's continuing struggle with food with 
additional cognitive factors such as increased preoccupation with food, 
weight and eating, further exacerbating the problem. 
Ward, Bulik and Johnson (in press) further suggest that dieting 
and binge eating are associated with mental suppression. They suggest 
that suppression of thoughts of food, weight and body shape can lead to 
an increase in frequency of these thoughts. Furthermore, dietary 
restriction is likely to be associated with successful suppression and 
binge eating with failed suppression. 
Psychological or emotion-based dimensions, such as feeling 
depressed, being bored or lonely, or experiencing food cravings, are 
common binge eating triggers. These types of feelings, rather than 
physiological factors such as hunger or prolonged dieting, are more 
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likely to be triggers (Bruce & Agras, 1992), further supporting the 
primacy of an individual's thought processes and mental state, in binge 
eating. Polivy and Herman (1985) conclude by stating that the causal 
link between dieting and bingeing can be traced to the dieter's 
imposition of cognitive controls. 
Eating disordered behaviour in JDDM populations 
Both case reports and empirical studies suggest that young 
women with IDDM maybe at high risk for developing eating disordered 
behaviour. Although it is agreed upon that such disordered eating 
occurs considerably more often in female patients, conflicting results 
have been reported concerning the relative prevalence of eating 
disordered behaviour in diabetic women versus non-diabetic women 
(Striegel-Moore, Nicholson & Tamborlane, 1992). Some evidence 
suggests that eating disorders among women with IDDM are more 
common than in the general population, whereas other studies 
conclude that IDDM patients have prevalence rates comparable with or 
even less than those observed among non-diabetic populations 
(Fairburn, Peveler, Davies, Mann & Mayou, 1991; Birk & Spencer, 
1989). These conflicting results may be attributable to methodological 
differences, including differences in definition, measurement of eating 
disorders and in sampling techniques. In addition, instruments for 
diagnosing eating disorders do not address the issue of insulin purging. 
The literature examining the area of IDDM and eating disorders is 
plentiful. Studies that have attempted to assess the prevalence of 
eating disorders among individuals with IDDM report estimates ranging 
from 7-35%, with an average estimate of 18% (Rodin, et al. 1986-87; 
Hudson, Wentworth, Hudson & Pope, 1985; Rodin, et al. 1985; 
Rosmark, Berne, Holmgren, Lago, Renholm, & Sohlberg, 1986; Steel, 
Young, Lloyd & Clarke, 1987). These estimates far exceed those 
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reported for the general population of young women (1.3-5%), which has 
led researchers to suggest that IDDM places women at risk for 
developing eating disorders (Shotte & Stunkard, 1987). 
Wing, et al. (1986) found that diabetic adolescents differed to 
controls on the EAT-26 questionnaire, ordinarily indicative of more 
eating pathology. However diabetic subjects scored higher only on the 
dieting subscale of this questionnaire, probably reflecting adherence to 
the diabetes dietary regimen. They also found that self-reported bulimic 
behaviour related to poorer glycemic control. Overall, this study 
indicates that adolescents with diabetes report more concern about 
their diet than non-diabetic control subjects. 
Striegel-Moore, et al. (1992) found that both IDDM and matched 
controls reported minimal symptoms of eating disorders. Those IDDM 
patients that did, related the eating disorder symptomatology to 
dissatisfaction with diabetes and its impact on their lives. This study 
had a small sample size however, and subjects were aged 8-18 years - a 
very wide age range to study. 
A study conducted by Stancin, et al. ( 1989) found that 58% of 
their sample of IDDM women reported episodes of binge eating, and 
12% met DSM-III criteria for bulimia. In an epidemiologic study 
conducted by Marcus, Wing, McDermott and Dodge (1990), 9% of 
responders indicated disordered eating and 13% reported at least 2-3 
binge eating episodes per month. Rodin, et al. (1985) found both 
bulimia and anorexia nervosa in 6.5% of their sample; a two-fold and 
six-fold increase respectively. 
Peveler, Fairburn, Boller and Dunger (1992) however, found that 
although adolescent girls with IDDM were heavier (body weight) and 
dieted more intensively to control their shape and weight, clinical eating 
disorders were no more common than among their non-diabetic 
counterparts. Similarly, Powers, Malone, Coovert & Schulman (1990) 
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did not find a higher prevalence of eating disorders among their sample 
of adolescent diabetic patients. However their sample included male 
and female IDDM patients with an average age of approximately 15.5 
years. It is now widely accepted that females account for over 90% of 
eating disordered behaviour (Bulik, 1994; APA, 1994). Although it is 
important to acknowledge the occurrence of such behaviour among 
males, the inclusion of male subjects may not allow for an accurate 
result regarding prevalence of eating disordered behaviour among IDDM 
patients. Additionally, their results may also reflect the low age of these 
young adults, in that they have not completely passed through the ages 
at greatest risk of developing eating disorders. 
Marcus, Wing, Jawad and Orchard (1992) conducted a register-
based study of IDDM women, and found that diabetic subjects were 
comparable, with regards to eating disordered symptomatology, to those 
of non-diabetic subjects in standardised samples. However eating 
disorder symptomatology among IDDM women is significantly 
associated with poorer control of diabetes. This study holds value in 
the sense that it is a register-based sample and had a large sample size 
(N=l88). Existing studies have tended to rely on clinic samples that 
may not be representative of the population of IDDM women. 
When addressing issues of severity of eating disordered 
behaviour, LaGreca, Schwarz and Satin (1987) found that most (85%) 
of their population of young women with IDDM reported at least 
occasional bingeing and that frequency of bingeing increased with poor 
glycemic control. 
Powers et al. (1990) highlight two important factors that may 
affect results and consequent conclusions in this area of study. Firstly, 
the criteria used for diagnosing eating disordered behaviour may differ 
from study to study, and secondly, methodological instruments also 
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differ between studies. Both these factors result in comparative 
difficulties. 
Insulin manipulation 
Insulin manipulation to promote weight loss or avoid weight gain 
can result in severe and potentially life threatening disturbances in 
metabolic control, an aspect which has received recent attention in the 
literature. Reasons for insulin omission may include fear of 
hypoglycemia, denial of illness, needle phobia, attention from others 
(secondary gain), and direct purging of calories as a method for 
managing weight (Polonsky, Anderson, Lohrer, Aponte, Jacobson & 
Cole, 1994). 
Survey research conducted by Stancin et al. ( 1989) found that 
nearly 40% admitted to controlling their weight by insulin purging 
(typically by decreasing their insulin dosage), and 13.5% reported 
purging by other means. In terms of resulting medical complications, 
bulimic symptoms were positively related to reports of hospitalisations, 
episodes of ketoacidosis, and psychological symptoms. Reliance on self-
report measures, a small sample size, and moderate response rate 
(65%) limit the generalisability of these results, however. 
Peveler and Fairburn et al. (1992) found that 15% of their 
subjects had omitted or reduced their insulin dosage to influence their 
shape and weight and that this was not limited to those subjects with a 
clinical eating disorder. This study however included both boys (51) 
and girls (35). A similar result of 12% was found by Rodin et al. (1991). 
Marcus, Wing and McDermott, et al. (1990) found that 31 % of their 
subjects, from an epidemiologic study, reported episodes of insulin 
manipulation to control weight and promote weight loss. 
Polonsky et al. (1994) additionally found that insulin omission in 
an outpatient clinic-based population is also common, and that it is not 
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limited to younger women. Approximately 31 % of the subject sample, 
representing women aged 13-60 years of age, reported intentional 
insulin omission, but only 8.8% reported frequent omission. Of the 
omitters, approximately half reported omitting insulin for weight 
management purposes. Of the other half, feelings of being emotionally 
overwhelmed by diabetes was paramount in promoting insulin 
omission. Omitters, especially those who omitted for weight 
management purposes, evidenced greater psychological distress, more 
hypoglycemic fear, poor regimen adherence, more diabetes related 
hospitalisations and higher rates of associated medical complications 
such as retinopathy and neuropathy. In addition, perhaps not 
surprisingly, Biggs, Basco, Patterson and Raskin (1994) found that 
women who withheld insulin for weight management reasons were more 
likely to report current or past symptoms of anorexia or bulimia nervosa 
and were more likely to report lying to physicians about their degree of 
compliance with their diabetes regimens. The results from the Biggs et 
al. (1994) study however must be interpreted cautiously as subject sizes 
were small (N=15) and there was a high refusal rate. Given these 
considerations, this sample may not be representative of all women who 
manipulate insulin. 
Interestingly, LaGreca et al. (1987) found that those individuals 
who reported poor glycemic control coped with overeating or bingeing by 
omitting insulin or by avoiding the use of insulin supplements. In a 
New Zealand study, Hockey, Brown, and Lunt (1993) found a 17% 
prevalence of insulin self-manipulation, for the purposes of weight loss 
in an IDDM population aged 18 to 30 years. This figure is considerably 
lower than that reported in overseas countries such as Britain and the 
United States. The reason for this difference is unexplained, although 
subject recruitment does differ and therefore results may not be directly 
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comparable. Those who did self-manipulate insulin tended to have a 
poorer glycemic control. 
Overall, these data indicate that insulin withholders for weight 
control reasons, exhibit more symptoms associated with the spectrum 
of eating disorders than non-insulin withholders (Biggs et al. 1994). In 
addition, they suggest that the link between omission and disordered 
eating may be complicated by important diabetes-specific factors. 
Although these data cannot indicate direction of causality, they suggest 
that specific attitudes, especially those associated with weight 
preoccupation, weight dissatisfaction (LaGreca, Schwarz, Satin, Rafkin-
Mervis, Enfield & Goldberg, 1990) and with feeling emotionally 
overwhelmed by diabetes, may be the strongest determinants of insulin 
omission and problematic eating patterns, such as binge eating. 
However weight related omission is markedly more pathological in 
nature than is non-weight related omission. Rodin et al. (1991) further 
suggest that intentional undertreatment with insulin, which causes 
hyperglycemia, to reduce weight and prevent weight gain, may be 
regarded as an equivalent to purging, with similar purpose and 
consequences. 
Clinically, it is important that clinicians recognise, acknowledge, 
and respect the importance of weight issues in their IDDM patients 
(Polonsky et al. 1994). Hockey et al. (1993) propose that health 
professionals should be aware of this method of weight reduction 
among their IDDM patients. Biggs et al. (1994) suggest that three 
measures are essential to significantly reduce the risk of serious 
complications as a result of insulin withholding: referral to a dietitian 
specialising in diabetes, close supervision of insulin administration by 
team members, and counselling by mental health professionals. 
Rosmark et al. (1986) and Striegel-Moore et al. (1992) view the 
increased prevalence rate of eating disordered behaviour among IDDM 
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patients as an important factor in the development of eating disorders. 
In other words, IDDM may be regarded as one risk factor in the 
potential development of eating disorders. 
Rodin and Daneman (1992) agree, stating that certain aspects of 
IDDM and its management may trigger the expression of an eating 
disorder in susceptible individuals. Required dietary restraint and 
weight gain related to diabetes management are the factors most likely 
to be implicated. There also appears a consistent finding that eating 
disordered symptomatology is associated with poorer blood sugar 
control and poorer health outcomes (Marcus, Wing, Jawad et al. 1992). 
Summary 
Although the prevalence of eating disordered behaviour is 
controversial and depends largely on the population sampled, IDDM 
appears a risk factor in the development of eating disorders. 
Furthermore, lesser degrees of disturbed eating may be more prevalent 
than eating disorders per se, amongst this population. Those 
individuals especially at risk are those who diet, intentionally 
manipulate insulin and/ or those who are overweight and/ or concerned 
about their weight and shape. At a minimum, females with IDDM 
report concern about their diet, dissatisfaction with the illness and its 
subsequent impact on their lives. 
Binge eating, insulin purging and poorer glycemic control also 
appear to occur together. Clinicians and health professionals should be 
aware of the relationship and consider the possibility of an eating 
disorder in cases where glycemic control is unexplained or uncontrolled 
(Marcus & Wing, 1988). At the very least, what does seem conclusive is 
that such behaviours compromise glycemic control, resulting in poorer 
physical, emotional and psychological outcomes. 
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Binge eating and Obesity 
Although Stunkard (1959) identified binge eating as a problem in 
the obese more that 35 years ago, it has only recently generated 
research interest. Telch, Agras and Rossiter (1988) found that binge 
eating was significantly more prevalent among the obese, increasing 
sharply in those individuals with BMI scores above 34. Telch et al. 
( 1988) consider that the dietary restriction involved in very low calorie 
diet prescriptions for the obese, may predispose them to binge eating 
upon refeeding. Furthermore, there may be additional individual, 
familial and societal pressures for obese individuals to maintain dieting. 
Keefe, Wyshogrod, Weinberger and Agras (1984) applied the DSM-
III criteria for bulimia to 44 obese patients and found that 23% of the 
sample met full criteria, with an additional 29% meeting all but one of 
the major criteria. Other researchers have reported binge eating 
percentages ranging from 20-46% of their overweight subjects (Marcus, 
Wing, & Lamparski, 1985; deZwaan, Nutzinger & Schoenbeck, 1992; 
Gormally, Black, Daston & Rardin, 1982; Loro & Orleans, 1981; 
Hawkins & Clement, 1980; Marcus & Wing, 1987); however, it is not 
clear from these studies which definitions of binge eating were used 
(Telch, et al. 1988). 
Spitzer, Devlin, Walsh, Hasin, Wing, Marcus, Stunkard et al. 
(1992) reported that Binge Eating Disorder (BED), as proposed by the 
DSM-IV, was relatively common among subjects attending weight loss 
programs (30%), but was relatively rare in the general population with 
only 2% meeting full criteria for BED. Similar findings were reported by 
Spitzer, Yanovski, Wadden, Wing, Marcus, Stunkard, Devlin et al. 
(1993). Thus, it is possible that those at the more severe end of the 
obesity spectrum, indicated by those attending weight loss programs, 
pose the real concern compared with community or clinic samples. 
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In a recent review of the literature on BED, deZwaan, Mitchell, 
Raymond and Spitzer (in press) concluded that obese binge eaters 
represent a substantial portion of the obese in weight control programs, 
and that they evidence more eating- and weight-related problems as 
well as general psychopathology compared to their non-binge eating 
obese counterparts, although less than their bulimic counterparts. 
This is also supported by Prather and Williamson (1988) whose results 
suggested a continuum of psychopathology severity. 
Additionally, Marcus, Smith, Santelli a.i-i.d Kaye (1992) found that 
obese binge eaters had considerable depressive symptomatology and 
that early onset obesity, frequent weight losses, and family histories of 
obesity were common. Many of these characteristics were also shared 
by normal weight bulimic subjects, thus suggesting behavioural and 
emotional similarities between the two groups. However this sample 
was small (n=l 7), and the subjects were treatment seekers, perhaps 
producing a sample biased towards severity. Telch et al. (1988) 
concluded that binge eating poses a serious problem among overweight 
individuals. 
Research findings have produced a mixed picture and have not as 
yet clarified the association, if any, between obesity and emotional 
disturbance. When data from community studies are considered, the 
general consensus is that psychopathology is no more common among 
the obese than among normal weight controls. By contrast, studies of 
obese individuals drawn from clinic populations have more con,sistently 
demonstrated increased psychopathology among these patient samples. 
For example, Black, Goldstein, and Mason (1992) found that obese 
patients were more likely to have a lifetime history of mood disorders, 
anxiety disorders, bulimia, and tobacco dependence. Additionally, the 
obese subjects were more likely to evidence one or more personality 
disorders. Regardless of the fact that overweight individuals who seek 
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treatment evidence more psychopathology than those who do not, Telch 
and Agras (1994) concluded that binge eating per se, not obesity, 
accounts for the observed relationship between obesity and 
psychopathology. 
Interestingly, Telch et al. (1988) found that none of the patients 
included in their sample reported self-induced vomiting or the use of 
cathartics or diuretics for weight control. This has been supported by a 
number of researchers who found that purging is less frequent in obese 
individuals than in normal weight binge eaters and other eating 
disordered populations (Hudson, Pope, Wurtman, Yurgelen-Todd, Mark 
& Rosenthal, 1988; Wardle & Beinart, 1981; cited in deZwaan, 
Nutzinger et al. 1992; Marcus & Wing, 1987; Mitchell, Pyle, Eckert, 
Hatsukami & Soll, 1990; Marcus, Wing, Ewing, Kern, Gooding & 
McDermott, 1990). 
Binge Eating and NlDDM 
There are a number of factors suggesting a possible association 
between binge eating and NIDDM. Firstly, obesity has been identified 
as a risk factor in the development of NIDDM. Secondly, as has been 
highlighted, considerable evidence suggests that binge eating may occur 
more readily in individuals with IDDM. Finally, the treatment of choice 
for obese patients with Type II diabetes is dieting to promote weight loss 
(Guare, Wing, Marcus, Epstein, Burton & Gooding, 1989) and, as has 
been discussed above there appears to be an association between 
dieting and binge eating. These factors considered, it seems imperative 
to address the issue of eating disordered behaviour among NIDDM 
populations. However, in contrast to the burgeoning literature on 
eating patterns, insulin self-manipulation and binge eating in Type I 
diabetic populations, there have been only a few systematic studies 
conducted which address this issue in Type II populations. 
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Th.ere appears some indication of the presence of binge eating in 
NIDDM. Firstly, using the Binge Eating Scale (BES), Wing et al. (1989) 
found that 21% of the female and 9% of the male subjects with NIDDM, 
met criteria for a serious binge eating problem. They concluded that 
binge eating is a common problem in obese Type II diabetic patients. 
A number of methodological flaws limit the findings and 
generalisability of the Wing study. First, the population sampled 
included males and females, and was pre-selected from a behavioural 
weight control population. As was noted previously in a review of the 
literature on binge eating disorder, deZwaan, Mitchell, Raymond and 
Spitzer (in press) found that obese binge eaters represent a substantial 
portion of the obese in weight control programs. Th.us, the Wing et al. 
(1989) study may have obtained a high prevalence rate of binge eating 
as their subject cohort were attending a weight loss program. In 
addition, they had a small sample (36 males and 62 females) and 
included no comparison group. Wing et al. (1989) suggested that 
further study was needed in this area and that clinical interviews 
should be a procedural inclusion as past studies have relied too heavily 
on the sole use of self-report measures. 
Interestingly, in the Wing study, binge eating was unrelated to 
weight or glycemic control in these patients, a result which differs from 
previous research on IDDM populations. Th.ere may be several 
explanations as to why binge eating is unrelated to glycemic control in 
this population. First, the effect of binge eating on glycemic control may 
be greater in patients who are insulin deficient (Type I) than those who 
are insulin resistant (Type II). Second, the binge behaviour of Type I 
diabetes may be more severe than that of Type II diabetic patients. 
Finally, the marked effect of binge eating on glycemic control in Type I 
diabetic patients may be due not only to the episodic consumption of 
large amounts of food but also to the omission of insulin doses, which 
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frequently accompanies binge eating (LaGreca et al. 1987). This latter 
technique for "wasting calories" would not be available to the Type II 
diabetic patient (even type II diabetic patients on insulin may have some 
endogenous insulin secretion in response to a binge) (Wing et al. 1989). 
In a second study, utilising interview and self-report techniques 
(BES) in a population of age, sex and weight-matched, newly diagnosed 
NIDDM patients, Kenardy, Mensch, Bowen and Pearson (1994) found 
that 14% of diabetic, compared with 4% of non-diabetic subjects 
reported episodes of binge eating, although there was no indication of 
any severe binge eating pathology. However there was no difference 
between the two groups in the prevalence with which they met criteria 
for binge eating disorder. They concluded that the relatively low rate 
may be due to insufficient sample size and associated power. 
Additionally, diabetic patients with a history of binge eating were 
significantly heavier, had younger age at diagnosis, and had more 
problems with eating in response to situational and emotional cues that 
did diabetic patients who did not binge. 
As this population was newly diagnosed NIDDM patients, the 
presence of abnormal eating behaviours may have been associated with 
increased dietary restraint following diagnosis. The study also focused 
on males (n=23) and females (n=27), which may affect the results. In 
addition, these results are unable to determine whether binge eating 
pathology is associated with illness duration, as is suggested by 
Lustman, Griffith, Clouse and Cryer (1986). 
Summary 
Binge eaters may represent a distinct subgroup among the obese 
population. Depending upon the population sampled, they may 
evidence more eating- and weight-related as well as general 
psychopathology, particularly major depression, and closely resemble 
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patients with bulimia nervosa in many respects. Interestingly, as 
observed by many researchers, a distinct difference between patients 
with bulimia nervosa and obese patients who binge is the infrequency 
with which overweight bingers purge, in comparison with bulimic 
patients. In addition, according to the few systematic studies that 
address the issue of binge eating in NIDDM populations, there appears 
an increase in binge eating behaviour compared with control 
populations, of which severity depends largely upon the sampled 
population. Furthermore, those who do binge may be responding to 
situational and/ or emotional cues. Due to the paucity of literature and 
methodological flaws in this area much research attention is warranted. 
As in most research areas, there are many methodological 
problems present in this literature. With few exceptions, many of the 
above mentioned studies use small samples (which results in a lack of 
statistical power and makes it difficult to detect any real effects), 
differing definitions of binge eating, combinations of male and female 
participants, subjects selected from different populations and different 
outcome measures. In addition, many do not utilise control groups. 
Wing et al. (1986) emphasised the need for further research with 
clinical interviews to obtain a better understanding of eating problems 
among individuals with IDDM and NIDDM. It has also been noted by 
many researchers (Wing et al. 1986) that eating habits are often 
underreported in IDDM and NIDDM patients, so as they appear 
adherent with their diabetes regimen. These issues prevent adequate 
between study comparison and are in part accountable for the 
controversy regarding the prevalence and severity of eating disordered 
behaviour among IDDM and NIDDM patients. 
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1.2.5 Depression and diabetes 
As part of the growing concern for optimal care and management 
of patients with diabetes mellitus the problem of depressive 
disturbances in these patients has been addressed. Furthermore, 
depression may have a special clinical relevance in diabetes through its 
purported association with poor glycemic control (Lustman, et al. 1986) 
and decreased adherence to treatment modalities (Gavard, Lustman & 
Clouse, in press). Inherent in this body of work is the belief that 
attention to the patient's emotional status (and particularly rnood) is 
requisite to the provision of optimal care and management of diabetes 
(Popkin, 1989). DeGroot and Samson (unpublished observations; cited 
in Jacobson, 1993) have found that the presence of a psychiatric 
condition, such as major depression, is associated with worsened 
quality of life independent of the severity of diabetes complications. 
Some researcher's question whether psychiatric diagnoses can be 
made with adequate reliability and validity in patients with concomitant 
medical conditions (Lustman, Amado & Wetzel, 1983). For example, 
some criterion symptoms for the diagnosis of depression (eg: fatigue, 
weight loss) are also symptoms of unstable diabetes. However 
Lustman, Griffith, Gavard & Clouse (1992) found that when using 
structured interviews and accepted psychiatric criteria, more than 90% 
of the depression cases were identified. They concluded that depression 
in medically ill patients can be detected using these instruments. 
Prevalence 
Historically, much of the work in this area has lacked 
methodological rigour, failing to include control samples or failing to 
differentiate between IDDM and NIDDM. The few available studies 
document high rates of major depression or a significantly increased 
mean level on depression symptom scales in diabetics. Not 
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surprisingly, it appears that depression often goes unappreciated, 
undetected and/ or untreated (Popkin, 1989). For example, in a 
population of both IDDM and NIDDM patients, Lustman et al. (1986) 
found that 33% of diabetic patients (aged 21 and older) had a lifetime 
history of major depression. This study hinted at slightly higher rates 
for NIDDM patients. 
Using an IDDM population, Popkin et al. (1988) observed a 
lifetime prevalence of 24% for major depression which could not be 
attributed to gender, age group, duration of illness, or the presence of 
various complications. This finding suggests a prevalence rate 5-6 
times that of the control group or the general population. This study 
however used a very small sample (n=14) and unique sample 
characteristics (candidates for pancreas transplantation). 
In NIDDM populations, current prevalence rates for depression 
include 21.8% (Wing et al. 1989), 27.3% (Weyerer et al. 1989) and 
26.1 % reported by Montague et al. (unpublished observations, 1992; 
cited in Lustman et al. 1992). A firm conclusion regarding whether 
depression is more common in type I or type II diabetes cannot be made 
as many studies have focused exclusively on one type. The available 
evidence suggests that the prevalence of depression in IDDM patients 
appears similar to that seen in NIDDM patients, despite important 
differences in the underlying pathophysiologies of the two illnesses 
(Lustman et al. 1992). However in one report (deGroot and Samson 
(unpublished observations; cited in Jacobson, 1993), the trend was 
toward more psychopathology (especially depression) in NIDDM 
patients. This trend does not appear related solely to greater obesity in 
NIDDM. 
Wing, Marcus, Blair, Epstein and Burton (1990) found that 
depression symptoms were greater in obese NIDDM subjects than in 
their similarly obese non-diabetic spouses. To identify the role of 
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obesity in depression precisely, it would be useful to compare two 
NIDDM groups, one obese and one nonobese. No evidence is currently 
available to indicate that depression prevalence differences are related 
to medications for diabetes or for other medical conditions (Lustman et 
al. 1992). 
Many claim that the rates of major depression in diabetic patients 
may prove comparable to the rates of major depression encountered in 
many other chronic debilitating illnesses. However although depression 
symptoms are, in general, more common in the 1nedically ill, diabetes 
appears to be at the high end of this continuum of depressive 
symptomatology severity in the medically ill (Weyerer et al. 1989). 
Clinical Presentation 
The mean age of onset of depression is 22.1 years in IDDM 
patients and 28.6 years in NIDDM patients (Lustman, Griffith & Clouse, 
1988). The age of onset of depression in the general population is 
typically 27-35 years (Weissman, Leaf, Tischler, Blazer, Karno, 
Livingston & Florio, 1988) which more closely resembles the NIDDM age 
of onset. In patients with NIDDM, the onset of depression appears to 
significantly precede the onset of diabetes, and the converse is true for 
IDDM patients (Lustman et al. 1988). 
A family history of depression is significantly more common in 
diabetic patients with depression (30%) compared with nondepressed 
diabetic patients (Lustman, Clouse, Carney & Griffith, 1987). 
Depression in diabetes appears to be predominantly a female illness, 
much as it is in the general population (Robinson, Fuller & Edmeades, 
1988), although Popkin et al. (1988) and Robinson et al. (1988) 
observed no gender difference in the prevalence of depression in IDDM 
and NIDDM patients, respectively. Further studies are needed to 
address this issue systematically. 
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With regards to symptomatic presentation, Lustman, et al. ( 1987) 
states that the symptomatic expression of depression in diabetes is 
analogous to depression in psychiatric patients without diabetes. In 
addition, diabetes per se (ie: diabetes in the absence of a diagnosis of 
depression) is associated with a slight increase in depression symptoms, 
generally similar to that observed in samples of patients seeking health 
care. Lustman and Clouse, et al. (1988) note that depression may also 
influence the symptomatic expression of diabetes. In a report 
examining the association of diabetes symptoms to glycemic control and 
to psychiatric illness, depression was associated independently with 
increased symptoms of the metabolic disease, such as polyuria and 
polydipsia. Furthermore, depressed and nondepressed diabetic patients 
remain easily distinguishable, particularly through the cognitive and 
neurovegetative symptoms of depression (Lustman et al. 1987) and they 
may have greater dissatisfaction with physical appearance (Wing et al. 
1990). 
Interestingly, Haire-Joshu, Heady, Thomas, Schechtman and 
Fisher (in press) found a strong relationship exists between diabetes 
and depression in smokers with diabetes. In addition, they note that 
the presence of depressive symptoms may inhibit smoking cessation 
efforts. In support, Lustman (1994) advocates that both smoking and 
alcohol abuse increase the risk of diabetes complications. 
Course 
Little is known about the course of affective illnesses in patients 
with diabetes or in other physically ill patients. In a 5 year follow-up 
study, conducted by Lustman and Griffith, et al. ( 1988) 79% of the total 
patients ill with affective disorder during the five year period 
experienced episodes of major depression or dysthymia. In contrast, 
the likelihood of symptomatic affective disorder was only 10% over the 
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same follow-up period in a comparison group of diabetic subjects 
without depression at the index evaluation. 
Occurrence of depressive episodes appeared independent of 
diabetes complications because both the depressed and comparison 
groups had similar rates of neuropathy, retinopathy, and nephropathy 
(Lustman and Griffith et al. 1988). However Leedom, Meeham, Procci 
and Zeidler ( 1989) question this finding, as they found that diabetic 
patients with complications scored significantly higher, than controls or 
patients without complications, on two measures of depression (Beck 
Depression Inventory and Zung Depression Scale), particularly on the 
cognitive aspects of depression. 
Aetiology 
Lustman et al. (1986) concluded that depression in diabetes may 
either cause or be caused by poor glucose regulation and that the 
presence of any psychiatric illness was associated with poorer long-term 
control of the diabetes. It has also been suggested that psychiatric 
illnesses, such as major depression, may themselves be intrinsic 
'complications' of diabetes (Jacobson, personal communication; cited in 
Popkin, 1989). 
Such a view is similarly held by Geringer (1990) who suggests 
that there may be a special relationship between depression and 
diabetes because of the abnormalities in the hypothalamic-pituitary 
adrenocortical axis, particularly cortisol response, common to both 
diabetes and depressive disorders. Diabetic individuals without 
depression also show the same abnormal response to dexamethasone 
suppression tests as do non-diabetic individuals who are depressed 
(Hudson, Hudson, Rothschild, Vignati, Schatzberg & Melby, 1984). 
Furthermore, functional deficiencies in norepinephrine and serotonin 
are believed to be associated with depression (Walsh, 1995), and these 
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neurotransmitters have also been implicated in animal models of 
diabetes (MacKenzie & Trulson, 1978). 
These endocrinological abnormalities and physiological 
associations may be consequences of the neurological and/ or metabolic 
derangement of both disorders. Although speculative, such 
physiological associations could corroborate the propensity of diabetic 
individuals for depression but not for other psychiatric disorders found 
by Weyerer et al. (1989) (Gavard et al. in press). 
There may also be other diabetes-specific linkages to depression. 
For example, irregular blood glucose control ( the rapid shifts between 
high and low blood glucose levels), could lead to affective lability and 
therefore depression in genetically at-risk individuals. However, even 
though many patients describe the mood shifts associated with changes 
in glucose levels, as yet no existing evidence suggests that repeated 
episodes of hypo- or hyperglycaemia have a permanent effect on mood 
disturbance (Jacobson, 1993). 
Popkin (1989) states that clinicians seem inclined to regard 
depression in diabetics as predominantly psychogenic or reactive in 
nature. This is supported by Robinson et al. (1988) who found that the 
presence of depression in diabetic patients was related to type of 
accommodation, marital status and amount of social contact. In 
addition, Peyrot and Rubin (1989) found that psychosocial factors 
accounted for the majority of the explained variance in their data, with 
coping styles and self-efficacy each accounting for 19%. Of further 
relevance, Palinkas, Barrett-Connor and Wingard (1991) concluded that 
depressive symptoms in individuals with Type II diabetes may be related 
to awareness of diabetic condition in addition to poor health. 
However, given macrovascular changes in kidney and retina, and 
comparable changes in small blood vessels of the central nervous 
system, physiological factors may have a role in the aetiology of 
38 
depression in diabetics. In addition, the prospect of a biochemical 
relationship between diabetes mellitus and depressive illness has been 
suggested, emphasising the lowering of insulin resistance and glucose 
utilisation in major depression, and restoration with resolution of the 
depression (Kronfol, Greden & Carroll, 1981). Collectively, these 
observations indicate that the clinician must give consideration to both 
psychological and physiological factors in the aetiology of depression in 
the diabetic. 
Lustman et al. (1992) thus conclude that depression in physically 
ill patients results from the initial occurrence or reoccurrence of 
depression: 1) in response to the psychosocial hardships imposed by, or 
intrapsychic factors related to, the medical illness; 2) as a result of 
biological changes directly related to the medical illness or its 
treatment; or 3) developing coincidentally with the medical illness, and 
resulting from biological, genetic, or psychological factors not caused by 
the medical illness. 
At present, the evidence is insufficient to explain entirely the 
increased prevalence of depression in diabetic patients. In fact, the 
cited data fail to fully exclude any hypothesis or possibility and 
probably best support a model that incorporates multiple mechanisms. 
This may explain why, in some controlled studies, depression seems 
more severe and prevalent in diabetic samples than in other medically 
ill subjects. 
Binge eating and depressive symptomatology 
Wing et al. (1989) found that binge eating symptomatology was 
strongly associated with depressive symptomatology. In addition 
numerous researchers (de Zwaan, Seim, Specker, Pyle, Crosby & 
Raymond, 1992; Marcus & Wing, 1988; Marcus, Wing, Ewing et al. 
1990; Wing et al. 1989; Hudson et al. 1988 and Spitzer et al. 1993) 
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have found that obese binge eater's exhibit higher depression scores, 
and are more likely to have a history of depression, than their non-
binge eating counterparts. In addition, Marcus, Wing, Guare, Blair and 
Jawad (1992) found that a history of major depression and depressive 
symptomatology are common among type II diabetic patients entering a 
behavioural weight-control program. 
Arnow, Kenardy and Agras (1992) found that bingeing appeared 
to be an attempt to cope with dysphoria among their population of 
obese individuals. Yet there is no evidence that binge eating brings 
significant relief from negative mood. Some subjects reported feelings of 
warmth and pleasure while bingeing, but feelings immediately afterward 
were universally characterised by guilt. Marcus, Wing and Hopkins 
(1988) found that binge eating was strongly associated with self-
reported dysphoria, and diet-related cognitions and behaviour. In 
addition, obese binge eaters, like their normal weight counterparts, 
appear to be preoccupied with weight, hold rigid and perfectionistic 
attitudes about dieting, and experience more impulsivity and less self-
esteem (deZwaan, et al. in press; Williamson, Kelley, Davis, Ruggiero & 
Blouin, 1985). 
The explanation for the association between binge eating and 
depression remains unclear. Depressive symptoms may be secondary 
to binge eating (Cooper & Fairburn, 1986), or binge eating may be 
secondary to depression (Pope & Hudson, 1988), or the association 
between binge eating and depression may be mediated by other 
variables. In the Wing et al. (1989) study, binge eating and depression 
changed together and thus made it difficult to ascertain the nature of 
the causal connection. 
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Summary 
Collectively, these data indicate that depression in diabetes is a 
common and chronic condition. Furthermore, in their review of the 
literature in this area, Gavard et al. (in press) suggest that diabetic 
individuals are at greater risk for depression than the general adult 
population. 
The causes of depression in diabetes remain largely unknown. 
Depression is probably determined by multiple factors, with the 
aetiological algorithm varying somewhat from one clinical case to the 
next (Lustrnan, 1994). Factors to consider include genetics, 
psychological factors, psychosocial hardships, noncompliance with 
medications, physical inactivity and obesity, precipitation by medical 
illness, organic abnormalities and physiological factors. 
It must be remembered however, that there are clear limits in the 
design of a lot of these studies and that gathering unbiased samples for 
accurate comparison of rates of disorder is extraordinarily difficult. 
These biases and methodological problems may interfere with the 
strength the presented conclusions. 
1.2.6 Rationale, aim and hypotheses of the present study 
The design of the present study was identical to that of Wing et al. 
( 1989). In the Wing study, binge eating was reported in 61 % of their 
pre-selected population. Methodological limitations of this study are 
addressed above. To date, it is not known whether this sample is 
representative of patients attending a diabetes clinic. Information on 
the prevalence of binge eating in a clinic population, and the possible 
association with other clinical and psychological features will thus be of 
use in the clinical and dietary management of NIDDM. 
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The objectives of this present investigation were threefold: 
1. To assess the prevalence and severity of binge eating and depressive 
symptomatology, and possible associations. It was predicted that the 
diabetic participants would indicate greater binge eating and depressive 
symptomatology than the controls. 
2. To evaluate the extent of dieting and dieting behaviour (for example, 
insulin purging and use of laxatives and vomiting for weight control or 
weight loss purposes). It was further predicted that the diabetic group 
would indicate more dieting behaviour than the controls. 
3. Establishing the relationship between age, binge eating, depressive 
symptomatology, self-manipulation of diabetes-specific medication, 
obesity, glycemic control, illness duration, medical illnesses and self-
monitoring of blood glucose (SMOBG) behaviour (whether one monitors 
their blood glucose levels). It was expected that there would be positive 
correlations between binge eating, depressive symptomatology, poorer 
glycemic control, obesity and self-manipulation of diabetes-specific 





Participants were recruited after ethical approval was granted by 
the Southern Regional Health Authority Ethics Committee (Canterbury) 
(SRHA). The diabetic participants were either discharged or current 
patients from a Diabetes Clinic register, who had been seen at least 
once previously at the Clinic. From these women, those fitting the 
following criteria were approached for recruitment. 
They were aged 60 years (inclusive) or younger, at study 
commencement date (14 November 1994), and had received the 
diagnosis of diabetes after the age of 30 years. However, if they were 
diagnosed before the age of 30 years, insulin treatment did not 
commence within one year of diagnosis. In addition, the women were 
all patients seen for physician review (including complications 
screening) between the dates of July 1992 and October 1994. A further 
small assortment of additional NIDDM patients meeting the above 
criteria were also located from co-workers referral (for example, 
dietitians and doctors). Essentially, the diabetic participants were a 
clinic based population of women with Type II diabetes. 
Prior to contacting the discharged patients, their General 
Practitioner's (GPs) consent was obtained in an attempt to rule out 
those patients who were unsuitable for the purposes of this study. In 
addition, the GPs of the current patients were sent a letter describing 
the proposed study and were given the opportunity to intervene 
regarding patient suitability. Upon GP consent, a letter outlining the 
study was sent to all eligible participants, followed by a phone call some 
time after to arrange possible interview times. 
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Each of the women that consented to participate were invited to 
bring a female friend/relative to the interview, who did not have 
diabetes and was aged between 31 and 60 years. These women 
composed the control group [termed 'friend controls' (Wacholder, 
Silverman, McLaughlin & Mandel, 1992)]. The rationale for use of 
friend controls was to control for demographics such as sex, age and 
socioeconomic status. In addition, friend controls may be more 
convenient and inexpensive than other alternatives (Wacholder et al. 
1992). The use of 'friend controls' will be discussed further in the 
discussion section. 
Consent forms and information sheets were sent to the 
participants which outlined the purpose of the study, participant 
requirements and gave assurance of confidentiality. However, diabetic 
participants were informed that with their consent their individual GPs 
would be contacted with glycated haemoglobin results. The information 
and consent forms sent to the diabetic participants differed so as to 
accommodate this information (see appendices). 
In addition, all participants were informed that should they 
indicate any desire to harm themselves (as indicated by item 9 on the 
Beck Depression Inventory) that a Clinical Psychologist was available, 
and would assess this risk and that GPs may be notified* . The 
participants were assured that they could withdraw from the study at 
any time, without recrimination, should the interview and/ or 
procedures cause any discomfort and/ or pain. Written informed 
consent was gained by the interviewers at the arranged appointment. 
* As both the Beck Depression Inventory (BDI) and the Binge Eating Scale (BES) are 
non-diagnostic in their clinical and research purpose, high scores on these measures 




From the aforementioned criteria, there were 205 women eligible 
for recruitment. Thirty-one of these women were excluded for various 
reasons. GPs excluded 4 due to mental illness/ disability or emotional 
instability. Seven were excluded by the researchers due to mental 
illness/ disability. Upon qualification of diagnoses, a further 7 were 
excluded as they were IDDM patients, or as their diagnoses was unclear 
at time of study commencement. Finally, 13 possible participants were 
not contactable, not living in the Christchurch area or deceased. One 
hundred and seventy-four possible participants remained, 55 of these 
refused participation when approached and the remaining 119 were 
recruited for study. This results in a participation rate of 68.4% of 
those eligible. 
2.2. Participants 
2.2.1 Diabetic Participants 
Diabetic participants were women with maturity onset diabetes 
(MOD) who were recruited from a Diabetes Clinic (n=l 19). Patients 
averaged 51.3 (5.9 SD) years of age, and had an average body mass 
index (BMI) of 33.0 (7 .6 SD). Fifty-three (44.5%) patients controlled 
their diabetes with insulin, 49 (41.2%) with oral medication, 11 (9.2%) 
with a combination of insulin and oral medication and 6 (5.0%) through 
diet only. An average glycated haemoglobin (HbA1), which measures 
glycemic control over the 2-3 months prior, of 8.5% (1.9% SD) was 
recorded. Of the 119 diabetic participants 104 (87 .4%), 11 (9.2%) and 4 
(3.4%) were of European, Maori and other ethnicities, respectively. 
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2.2.2 Control Participants 
Control participants averaged 4 7 .6 (9.3 SD) years of age and had 
an average BMI of 27.7 (5.5 SD). Seventy-four (94.9%) and 4 (5.1%) 
were of European and Maori ethnicities, respectively. 
2.3. Materials 
Measures used were the Beck Depression Inventory (BDI), the 
Binge Eating Scale (BES) and a semi-structured interview schedule 
designed specifically for this study (see appendices). 
2.3.1 Standardised Tests 
Beck Depression Inventory (BDll 
The BDI was originally developed by Beck, Ward, Mendelson, 
Mock and Erbaugh (1961). The revised version of the BDI was used in 
the present study to assess current (two weeks prior to interview) mood 
and symptoms of depression. It is one of the most widely used 
instruments to measure depression in both clinically diagnosed and 
control populations, thus enhancing the comparability of results. It is 
useful in measuring the severity or intensity of depression in adults and 
adolescents, rather than as a sole means of diagnosis. 
The revised BDI (Beck, Rush, Shaw & Emery, 1979) is a 21 item 
self-report instrument, in multiple choice format. It assesses the 
presence and severity of affective, cognitive, motivational and vegetative 
components of depression. Each item represents a depressive symptom 
or attitude, such as guilt feelings, social withdrawal or loss of appetite. 
Each of the 21 symptoms is composed of four statements rated from 0 
to 3 in increasing levels of intensity. 
The scale demonstrates high reliability and validity (Beck, Steer & 
Garbin, 1988), such as high internal consistency alpha of 0.86 (range 
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0. 76-0.95). Content validity indicates that the BDI reflects 8 I 9 DSM-111-
R criteria for major depression. Concurrent validity is moderately high 
(range 0.59-0. 76) with other instruments that measure depressive 
symptomatology, such as the Hamilton Rating Scale. In addition, 
various studies, as stated by Beck et al. (1988), show that the BDI 
discriminates between psychiatric and non-psychiatric patients. 
The dependent measure for this study was the raw score obtained 
on the BDI. Cut off scores are less than 10 (none or minimal 
depression); 10-18 (mild-moderate depression), 19-29 (moderate to 
severe depression) and 30-63 (severe depression) (Beck et al. 1988). 
Binee Eatine Scale {BES) 
Binge eating symptomatology was assessed with the BES, which 
is a standardised measure of assessing binge eating symptomatology 
(Telch & Agras, 1994). The BES was developed by Gormally, Black, 
Daston and Rardin in 1982 to assess binge eating in obese populations. 
However it also corresponds well with independent assessments of 
binge eating (Marcus, Wing & Hopkins, 1988). It is a 16 item self-report 
instrument that is designed to assess both behavioural manifestations 
(eg: eating large amounts of food) and cognitions surrounding a binge 
episode (for example, guilt). It includes questions related to 
preoccupation with weight and food, inability to control urges to eat, 
feelings of guilt and self-hatred after eating, and frequency of strict 
dieting. 
Gormally et al. (1982) found that the BES discriminated between 
patients with no, moderate, or severe binge eating problems. Higher 
scores indicate more bulimic behaviours. In addition, Gormally et al. 
(1982) stated that the BES appeared to have high internal consistency. 
The mean BES score reported by Gormally et al. (1982) for severe binge 
eaters in their normative sample was 28.9. In another study using a 
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cut off score on the BES of greater than or equal to 27 to indicate severe 
binge eating problems, Marcus, Wing, and Hopkins (1988) reported that 
98% of individuals whose score in the BES indicated severe binge eating 
problems met DSM-III criteria for bulimia, compared with none of those 
whose BES score indicated few problems. 
In addition, this measure has been shown to be a reliable and 
valid instrument for assessing eating behaviours in diabetic and non-
diabetic populations (Wing et al. 1989). Furthermore, scores on the 
BES have been shown to correlate with HbA1 levels in type I diabetic 
patients (Wing, et al. 1986). 
The dependent measure for this study was the raw score obtained 
on the BES. As there are no established cut off scores for the BES, 
those suggested by Marcus, Wing, and Hopkins (1988) were utilised in 
the current study. They are: raw score of 17 or less (little or no 
problem), 18-26 (moderate) and 27 or higher (severe binge eating 
problems). 
2.3.2 Semi-structured Questionnaire 
The diabetes questionnaire was designed specifically for the 
purposes of this study. The diabetic participants' version included 
questions pertaining to demographics, diabetes management, historic 
and current eating patterns and weight control, knowledge about 
diabetes and weight issues. The control participants' version was 
identical, however, did not include questions regarding diabetes 
management. 
2.4 Procedure 
The procedure was explained on initial telephone contact with the 
participants, in the information sheet provided, and/ or at the arranged 
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appointment time, prior to obtaining written informed consent from 
each participant. The majority of the testing took place at the Diabetes 
Clinic, however, a few home visits were made for the convenience 
and/ or comfort of the participant. 
Each of the participants were interviewed individually by one of 
the two available interviewers. All participants' completed the BDI, the 
BES, and the semi-structured questionnaire. In addition, participants' 
weight and height were obtained. Weight was obtained on either a 
balance beam (obtained while participant sits on scale) or standing 
scale (Seca brand), both with identical calibration, with the participants' 
in their usual clothes without shoes. Height was measured using either 
one of the two available Toledo height scales, which measure vertically 
from the floor and have sliding measurement markers. 
Glycaemic control was measured using glycated haemoglobin 
(HbA1) and blood sugar readings (current) which were obtained from the 
diabetic participants'. HbA1 was measured using a capillary blood 
sample on the Bayer DCA 2000 machine. The laboratory norm for this 
machine is 5.3%. Current blood sugar levels were measured using a 
Glucocard machine meter. Should the diabetic participants HbA 1 have 
been either lower than 3.5 mmol/L (indicating hypoglycemia) or higher 
than 20 mmol/L (indicating hyperglcemia), it was discussed with the 
participant, and a nurse contacted if required. 
The testing took approximately 1-1.5 hours and morning or 
afternoon tea was offered to all participants. Data were collected 
between the months of November 1994 and February 1995. 
Prior to testing, the procedure was piloted on six participants' (2 
control participants, 2 insulin-dependent diabetic participants' and 2 
non-insulin dependent diabetic participants'). Upon feedback from the 
participants', few alterations were made to the semi-structured 
questionnaire(s) and testing began. 
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As a check on the reliability of the coding (see appendices), an 
independent post-graduate research assistant, who was not involved in 
data collection, assessed the accuracy of the coding. Participant 
confidentiality was maintained. Data were entered and analysed using 




3.1 Demographic details: diabetics 
The main diabetes treatment method was insulin, followed by 
tablets, insulin and tablets and diet only. The majority (75.6%) of the 
diabetic participants had not had any hospital admissions due to 
diabetes. Furthermore, the majority (96.6%) of the diabetic participants 
reported self-monitoring of blood glucose, with most (84.9%) using a 
machine meter. In addition, the average duration of diabetes was 9.7 
(6.7 SD) years, with a range of 1-30 years (see table 3). 
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Table 3 
Demographic details: diabetics (N=l 19) 
N (%) 
Characteristic 
Main treatment method 
Insulin 53 (44.5) 
Tablets 49 (41.2) 
Insulin and Tablets 11 (9.24) 
Diet only 6 (5.04) 
# hospital admissions 
None 90 (75.6) 
One 25 (21.0) 
1\vo 2 (1. 7) 
Four 2 (1.7) 
SMOBG behaviour 
No 4 (3.4) 
Yes 115 (96.6) 
# SMOBG in last week 
None 18 (15.7) 
One-Four 37 (32.2) 
Five-Eight 22 (19.1) 
Nine-1\velve 18 (15.7) 
Fourteen-1\venty- 21 (18.3) 
eight 
SMOBG method 
machine meter 101 (84.9) 
strips against bottle 15 (12.6) 
machine meter and 
strips against bottle 2 1. 7) 
no method reported 1 (0.8) 
M (SD) 
Illness Duration 9.7 (6.7) 
3.2 Current medical problems and medication use 
Comparing reported medical problem(s) and medication use, 
using Pearson's Chi-square analyses and Fisher's two-tailed Exact Test, 
diabetic participants reported significantly more medical problems (not 
associated with diabetes) :x;2(1) = 7.9; p<.005 and, perhaps not 
surprisingly, greater medication use than the controls :x;2(1) = 9.2; 
p<.005. Upon breakdown of these medical problems, the diabetic 
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participants reported significantly higher blood pressure, as a group, 
than the controls, p=.005. No differences were found for the remaining 
medical illnesses reported (see table 4). 
Table 4 
Current medical problems and medication use (not associated with 
diabetes). 
Diabetics Controls x,2 p value 
N (%) N (%) 
Medical 
problem(s) 79 (66.4) 36 (46.2) 7.9 .005 
Thyroid 10 (12.7) 5 (13.9) .3 .6 
Depression 4 (5.1) 3 (8.3) .03 .9 
Other 
psychiatric 
(see 3 (3.8) - FET .3 appendices) 
High 8 (10.1) 1 (2.8) FET .09 
cholesterol 
Heart (eg: 
angina) 12 (15.2) 2 (5.5) FET .05 
High BP 21 (26.6) 2 (5.5) FET .005 
Hypertension 16 (20.3) 8 (22.2) .45 .5 
Asthma 12 (15.2) 6 (16.7) .001 .97 
Other (see 
appendices) 36 (45.6) 17 (47.2) 1.7 .2 
Use of 
medication 72 (60.5) 30 (38.4) 9.2 .005 
3.3 Reliability Check 
As stated, a reliability check* was conducted on 33% of the coded 
questionnaire data, by an independent research assistant. A high level 
of reliability was reported for all questionnaires. The BES - total and 
individual scores - for controls was 100%, and diabetics 99.9%. The 
BDI - total and individual scores - for controls was 99.9%, and diabetics 
* The formula used was total items agreed/ total items x 100 / 1. 
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99.9%. Finally, the coding reliability for the diabetes questionnaire was 
99.6% for controls and 99.8% for diabetics. 
3.4 Hypothesis One 
The objective of hypothesis one was to assess the prevalence and 
severity of binge eating and depressive symptomatology (using the BES 
and BDI, respectively), and possible associations. According to the past 
literature in this area, it was predicted that the diabetic participants 
would score higher on the BDI and BES than the controls. Using the 
Shapiro-Wilk test for normality, the BDI and BES scores for the control 
and diabetic participants were found to be non-normally distributed. 
Therefore, non-parametric statistical analyses, or square root 
transformations were used. One subject (#141) did not complete the 
BDI and the BES due to her emotional state at the time of interview, 
thus n=l18. 
Binge eating symptomatology 
The cut-off criteria scores, suggested by Marcus and Wing ( 1988) 
were used in this study as no standardised cut-off scores exist for the 
BES. Using the transformed variables, an ANOVA showed that the 
diabetic participants scored significantly higher on the BES, than the 
control participants (F (1, 194)=7.6, p=.006) (see table 5). 
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Table 5 
BES total and cut-off scores for control and diabetic participants 
Characteristic Controls Diabetics t p value 
(n=78) (n=l 18) 
M (SD) M (SD) 
BES total score 4.5 (4.2) 7.4 (6.9) 7.6 .006 
Cut-off scores N (%) N (%) 
Little-no problem (<17) 78 (100) 108 (91.5) 
Moderate problem (18-26) - 8 (6.8) 
Severe problem (27 +) - 2 (1.7) 
Depressive symptomatology 
The cut-off scores outlined by Beck et al. (1988) were used for 
this study. Using the transformed variables, an ANOVA showed that 
the diabetic participants scored significantly higher on the BDI than the 
control participants (F (1, 194)=9.6, p=.002) (see table 6). 
Table 6 
BDI total and cut off scores for diabetic and control participants 
Characteristic Controls (n=78) Diabetics (n=l 18) t p value 
M (SD) M (SD) 
BDI total score 5.8 (5.1) 9.0 (8.3) 9.6 .002 
Cut-off scores N (%) N (%) 
none-minimal 60 (76.9) 80 (67.8) 
(<10) 
mild-moderate 15 (19.2) 23 (19.5) 
(10-18) 
moderate- 3 (3.9) 10 (8.5) 
severe (19-29) 
severe (30-63) - 5 (4.2) 
55 
Relation between BES and BDI 
Using the transformed variables, the BDI and BES total scores 
(combined diabetics and controls) were significantly correlated (r=.4 7, 
p<.00005), as were the BDI and BES total scores for the diabetic (r=.49, 
p<.00005) and control groups (r=.35, p<.002). When analysing the 
association between the BDI and BES scores, using Wilcoxin Chi-
square, a significant interaction was found between the BDI severity 
[according to the Beck et al. (1988) cut-off scores] and BES total scores 
for the diabetic participants x2(3)=30.1, p<.00001. However, no 
significant result was found for control participants. This result 
suggests that a higher BDI score is associated with a higher BES score 
for the diabetic, but not the control participants. 
3.5 Hypothesis Two 
The objective of hypothesis two was to evaluate the extent to 
which dieting and dieting behaviour (for example, insulin purging and 
use of laxatives and vomiting for weight control or weight loss purposes) 
occurs in a clinic population of women with type II diabetes. According 
to the literature, there is an association between dieting and eating 
disordered behaviour. It was predicted that the diabetic group would 
indicate more dieting and eating disordered behaviour than the control 
group. 
Satisfaction and concerns with current body weight and shape 
Comparing satisfaction with current weight and body shape and 
concerns with current weight and shape, using Pearson's Chi-square 
analyses, a significant difference was found between the diabetic and 
control participants x2 (1)= 7.4; p<.02, with diabetics reporting higher 
dissatisfaction than controls, and controls reporting higher satisfaction 
than diabetics, with their current weight and body shape (see table 7). 
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No significant differences were found when comparing concerns, 
with similar numbers of diabetic and control participants reporting 
concerns with current weight and body shape, 74.8% and 73.1% 
respectively. Furthermore, similar numbers of control and diabetic 
participants reported their main weight concern as desiring to decrease 
weight, 67.9% and 69.7% respectively (see table 7). 
Several other concerns were highlighted by the control and 
diabetic participants with regards to current weight and body shape. Of 
these, the main concerns indicated were health concerns, with similar 
numbers of diabetic and control women reporting these, and desire for a 




Satisfaction and concerns with current body weight and shape 
Controls Diabetics x,2 p value 
(n=78) (n=119) 
N (%) N (%) 
Characteristic 
Satisfaction with 
current weight 7.4 .02 
Dissatisfied 23 (29.5) 58 (48. 7) 
Moderately satisfied 34 (43.6) 40 (33.6) 
Very satisfied 21 (26.9) 21 (17 .6) 
Concerns with 
cWTent weight and 
body shape .2 .6 
Yes 57 (73.1) 89 (74.8) 
No 21 (26.9) 28 (23.5) 
Not indicated - 2 (1.7) 
Weight concerns .7 .7 
Not indicated 24 (30.8) 34 (28.6) 
Increase wei.e:ht 1 (1.3) 2 (1.7) 
Decrease wei.e;ht 53 (67.9) 83 (69.7) 
Other concerns 
Health 6 (7.7) 6 (5.0) 
Clothin.e: 4 (5.1) 4 (3.4) 
Bone structure 3 (3.8) -
Other comments 1 (1.3) -
Toned body 2 (2.6) 14 (11.8) 
Self-esteem and 
confidence - 1 (0.8) 
More stable weight - 1 (0.8) 
Dieting Behaviour 
Comparing dieting behaviour, using Pearson's Chi-square 
analyses and Fisher's Exact Tests, there were no differences between 
the diabetic and control groups on lifetime prevalence of dieting, 
however there was a trend towards a higher rate of dieting amongst the 
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diabetics. In addition, the mean age at which participants reported 
beginning dieting was similar, however there was a trend for diabetics 
to begin earlier (see table 8). 
Diabetic participants reported a significantly greater lowest BMI 
(F (1, 193)=16.9, p=.0005), and highest BMI (F (1, 194)=27.0, p=.00005), 
than the controls. In addition, the diabetics also had wider ranges on 
these two variables. Overall, this suggests higher weights and greater 
weight fluctuation for the diabetic participants in comparison to the 
controls (see table 8). 
No significant differences were found between the two groups on 
the lifetime prevalence of use of diet pills, vomiting and exercising for 
weight and shape related purposes. However, there was a trend 
towards the diabetic participants having a higher use of diet pills, and 






Controls Diabetics x,2 p value 
(n=78) (n:119) 




dieting 45 (57.7) 83 (69.7) 3.0 .08 
Age at first diet 27.5 (mean) 27.0 (mean) 
12.4 (SD} 11.4 (SD) 
11.0 - 53.0 5.0 - 56.0 
years (ranj;!e) years (ranj;!e) 
# of diets in past 
year 
None 61 (78.2) 93 (78.2} 
One 12 (15.4) 15 (12.6) 
Two 2 (2.6) 4 (3.4) 
Three - 3 (2.5) 
Four 1 (1.3) 2 (1.7) 
Five 1 (1.3) -
Six 1 (1.3) 1 (0.8) 
Seven - 1 (0.8) 
BMI ranges t p value 
Lowest 21.2 (mean) 23.9 (mean) 16.9 .0005 
3.0 (SD) 5.2 (SD) 
15.0-31.2 14.2-40.7 
(range) (range) 
Highest 29.6 (mean) 35.5 (mean} t p value 
6.2 (SD) 8.7 (SD) 27.0 .00005 
20.0-47.6 19.2-56.8 
(range} (range) - -
Lifetime 
prevalence of 
diet pill use 8 (10.3) 15 (12.6) .25 .6 
Lifetime 
prevalence of 
vomiting 3 (3.8) 3 (2.5} FET .7 
Lifetime 
prevalence of 
exercisin! 58 (74.4) 78 (65.5) 1.7 .2 
Reasons for not dieting 
Comparing responses to the question "are there any particular 
worries or reasons that stop you from dieting?", using Pearson's Chi-
square analyses, no significant difference was found between control 
and diabetic participants, with similar numbers of both groups 
indicating that there were reasons for not dieting (see table 9). 
Furthermore, similar numbers of control and diabetic participants 
reported that dieting was not necessary ( 17. 9% and 16.0%, 
respectively). Other reasons for not dieting included damage to health, 
which was reported similarly by both groups. In addition, 10.9% of the 
diabetic participants reported that they did not diet because of their 
diabetes (see table 9). 
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Table 9 
Reasons for ,wt dieting 
Controls Diabetics x,2 p value 
(n=78) (n:119) 
N (%) N (%) 
Reasons for not 
dieting 39 (50.0) 60 (50.4) .004 .95 
Not necessary 14 (17 .9) 19 (16.0) 
Not happy when 
dietin~ 1 (1.3) -
Misses food - 2 (1.7) 
May cause illness 1 (1.3) -
If unwell - -
Irregular periods 
and decreased 
ener!!V 3 (3.8) -
Pointless 4 (5.1) 3 (2.5) 
Lack of will-power 
5 (6.4) 6 (5.0) 
Low blood su~ars 1 (1.3) 1 (0.8) 
Damru!es health 7 (9.0) 4 (3.4) 
Finances 1 (1.3) 3 (2.5) 
Diabetes - 13 (10.9) 
Self-defeating; - 2 (1.7) 
Worry if did not 
stay on it - 1 (0.8) 
Family 
commitments - 1 (0.8) 
Lifestyle too busy - 4 (3.4) 
Dieting; is borinJ;! - 1 (0.8) 
Dieting increases 
pressure - 3 (2.5) 
Diabetes Kiwwledge 
In response to the question "Do you think having diabetes affects 
weight?", using Pearson's Chi-square analyses, no difference was found 
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between groups, with a similar number in both groups suggesting that 
diabetes does affect a person's weight (see table 10). Trends indicated 
that more diabetics than controls believed that diabetes increases 
weight, whilst m01~e controls than diabetics indicated that diabetes 
decreases weight. 
When questioned regarding other ways in which diabetes may 
affect a person's weight many other possibilities were indicated (see 
table 9). Of these other possibilities, similar numbers of the control and 
diabetic participants (7. 7% and 10.9% respectively) indicated that 
obesity is a risk factor for developing diabetes. Furthermore, 11.8% of 
the diabetic participants reported that it is harder to lose weight when 
one has diabetes (see table 10). 
The diabetic participants were questioned as to whether they felt 
that diabetic medication affects their weight. Many (30.3%) indicated 
that diabetes medication does affect body weight. Of these, 21.8% 






Controls Diabetics x,2 p value 
(n=78) (n:119) 
N (%) N (%) 
Characteristic 
Diabetes affect body 
weight 62 (79.5) 92 (77 .3) 1.2 .3 
Increases weight 17 (21.8) 32 (26.9) 
Decreases weight 25 (32.1) 18 (15.1) 
Other possibilities 
Bi~-overwei~ht people 4 (5.1) 2 (1.7) 
Obesity is a risk factor 6 (7.7) 13 (10.9) 
Become either under-
or over-weie:ht 3 (3.8) 1 (0.8) 
Eating and lifestyle 
chan~es 8 (10.3) 2 (1.7) 
Weight fluctuations 4 (5.1) 6 (5.0) 
Small people 1 (1.3) -
Diabetes forces one to 
eat - 7 (5.9) 
Hard to lose weie:ht - 14 (11.8) 
Increased appetite - 1 (0.8) 
Has maintained 
weight - 2 (1.7) 
Attitude and lifestyle - 1 (0.8) 
Speeds up metabolism - 1 (0.8) 
Need to lose weight as 
part of diabetes 
management - 1 (0.8) 
Does diabetes-
specific medication 
affects body weight? - 36 (30.3) 
Increases weie:ht - 26 (21.8) 
Decreases weie:ht - 6 (5.0) 
Diabetes-specific medication self-manipulation 
The majority of the diabetic participants (62.3%) reported that 
they do not always take their recommended dose of diabetes-specific 
medication. Of those that replied, the majority (13) indicated that they 
decrease their dose of medication. Several other reasons were reported 
for altering the dose of their medication (see table 11) of which the most 
common were forgetting/too busy and altering their medication due to 
their blood sugar levels and level of exercise. Although 10 (8.4%) had 
thought about altering their medication for weight/ shape purposes only 
8 (6.7%) reported having done so (see table 11). 
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Table 11 





Always take recommended 
dose 
Yes 39 (32.8) 
No 74 (62.2) 
Increase recommended 
dose 2 (1.7) 
Decrease recommended 
dose 13 (10.9) 
Reasons 
Blood suR;ars and exercise 19 (16.0) 
Food eaten 4 (3.4) 
For~ets, too busy 40 (33.6) 
If away 5 (4.2) 
If consumin~ alcohol 1 (0.8) 
Financial 2 (1.7) 
Doctors advise 1 (0.8) 
Weight/ shape purposes 
Thought about altering 
medication? 10 (8.4) 
Done it? 8 (6.7) 
In the last month? 1 (0.8) 
3.6 Hypothesis Three 
The objective of hypothesis three was to establish the relationship 
between age, binge eating, depressive symptomatology, self-
manipulation of diabetes-specific medication, obesity, glycemic control, 
illness duration, medical illnesses and SMOBG behaviour, within the 
diabetic participants. It was expected that there would be positive 
correlations between binge eating, depressive symptomatology, poorer 
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glycemic control, obesity and self-manipulation of diabetes-specific 
medication. 
Significant correlations were found between BES score and 
glycemic control (r=.28; p<.002), between BES score and BMI (r=.27; 
p<.003), between BMI and glycemic control (r=.30; p<.001), between 
highest BMI and BES score (r=.31; p<.0008) and between BMI range 
and BES score (r=.28; p<.003). Furthermore, glycemic control was 
significantly related to BMI range (r=.26; p< .006). These results 
suggest an association between body weight, weight fluctuations, 
glycemic control and binge eating symptomatology. It appears that 
higher body weight is associated with worse glycemic control. In 
addition, obesity and weight fluctuations are also correlated with binge 
eating symptomatology. A non-significant result was found between 
SMOBG and BES score, indicating that binge eating symptomatology is 
not correlated with SMOBG behaviour. 
Significant correlations were also found between BDI score and 
glycemic control (r=.29; p<.001), between BDI and BMI (r=.13; p<.15) 
and between BDI and BMI range (r=.18; p<.05). As with the BES 
correlations above, these results suggest that depressive 
symptomatology is related to glycemic control, higher body weight and 
weight fluctuations. A non-significant result was found between 
SMOBG and BDI score and BDI and highest BMI, suggesting that 
depressive symptomatology is not correlated with SMOBG behaviour or 
highest body weight. 
Effects of dieting 
The diabetic group was then divided into dieters and non-dieters 
based on response to the question "have you ever changed your eating 
patterns or been on a diet to lose weight?". Using ANOVAs, those 
individuals who reported dieting, scored significantly higher on the BES 
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(F(l, 116)=13.6, p=.0003), had higher current BMis (F (1, 116)=27.2, 
p=.00001), poorer glycemic control (F (1, 113)=4.6, p=.03), reported 
higher weights (F (1, 116)=29.9, p=.00001), and greater weight 
fluctuations (F (1, 115)=9.8, p=.002). These results strongly suggest 
that dieting behaviour is related to BMI, obesity and weight 
fluctuations. Furthermore, dieting also appears related to binge eating 
symptomatology and, to a lesser degree, to depressive symptomatology, 
glycemic control and SMOBG behaviour. The existence of one or more 
medical illnesses, as indicated by a 'yes' or 'no' response, was also 
correlated with the ever dieting variable (r=.23, p<.01), suggesting that 
dieting is related to medical illnesses. Ever dieting was not significantly 
related to BDI and SMOBG. 
Age of first diet 
Age of first diet was significantly negatively correlated with 
highest BMI (r=-.3, p<.005) and DCA result (r=-.26, p<.01), suggesting a 
negative association between age at first diet and glycemic control. 
Furthermore, age was negatively correlated with BES score (r=-.19, 
p<.04). This result is suggestive of a negative association between age 
and binge eating symptomatology. 
Presence of Medical illnesses 
The diabetic group was divided into those with, and those without 
medical illnesses (not associated with diabetes), based on their response 
to their question "do you have any medical illnesses or conditions not 
associated with diabetes?". The existence of either one or more medical 
illnesses was not significantly related to illness duration, age at first 
diet, SMOBG behaviour, DCA result, BES score or age. However, it was 
significantly related to BMI range (F (1, 115)=7.5, p=.007), highest BMI 
(F (1, 116)= 11.7, p=.0009), BMI (F (1, 116)=9.1, p=.003), and BDI score 
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(F (1, 116)=4.8, p=.03). These results strongly suggest that medical 
complications are related to weight, weight fluctuation and obesity, and 
to a lesser degree, depressive symptomatology. 
Illness Duration 
Illness duration was not significantly correlated with ever dieted, 
BMI range, highest BMI, SMOBG behaviour, BMI, BES score and age at 
first diet, however was significantly correlated with glycated 
haemoglobin result (r=.2, p<.03), suggesting an association between 
illness duration and glycemic control. 
Self-manipulation of diabetes specific medication 
Self-manipulation of diabetes-specific medication was not 
significantly correlated with medical illness, illness duration, age, BMI 
range, SMOBG behaviour, DCA results, BMI, highest BMI, BDI score 
and BES score, yet was significantly correlated with ever dieted (r=. 76, 
p<.01). These results suggest that diabetes-specific medication self-




This section will commence with an explanation of the results 
found in this study, and their relevance to the past literature. 
Secondly, the strengths and limitations of this study will be discussed, 
and finally, conclusions and possible future research areas will be 
addressed. 
4.1 Explanation of the results 
Hypothesis One 
Hypothesis One aimed to assess the prevalence and severity of 
binge eating and depressive symptomatology, and any associations 
between them. It was hypothesised that the diabetic participants would 
score higher on the BES and BDI than the control subjects. This 
hypothesis was supported by the present study. Furthermore, 
associations were also found between binge eating and depressive 
symptomatology. 
Binge Eating Symptomatology 
The diabetics indicated a higher prevalence and severity of binge 
eating symptomatology, than the controls, thus supporting the 
proposed hypothesis. All of the control participants, 78 (100%) and the 
majority of the diabetic participants, 108 (91.5%) reported little or no 
binge eating, while 8 (6.8%) of the diabetics reported moderate binge 
eating and 2 ( 1. 7%) reported severe binge eating problems. It is 
possible that many of the diabetic participants' responses on the BES 
may have reflected factors such as diet restriction in response to their 
recommended diabetic diet. This should be considered when 
interpreting this finding. 
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This result differs substantially from Wing et al. (1989), in which 
they found that 21 % of the females in their sample met criteria for a 
serious binge eating problem. There are several possible explanations 
for this difference. Firstly, cultural differences may exist between the 
New Zealand and American interpretations of the BES. These possible 
differences in cultural interpretation may result in overall different 
scores on the BES and thus, different rates of binge eating 
symptomatology reported. 
Secondly, there may be an actual cultural difference in the 
prevalence of binge eating in New Zealand and the United States, more 
specifically, the United States may have a higher rate of binge eating 
symptomatology than New Zealand. Thirdly, our population had a 
lower BMI, on average (33.0) than the patients in the Wing study (36.7) 
and as binge eating appears associated with higher body weight (Telch 
et al. 1988), this may partly explain the lower prevalence of binge eating 
found in the present study. 
Fourthly, the Wing et al. (1989) study used BES criteria cut-off 
scores suggested by Marcus, Wing and Lamparski (1985), whilst the 
present study used those suggested by Marcus and Wing ( 1988). Using 
those suggested by Marcus et al. (1985) a high score on the BES is 
indicated by a score of 25+, whereas according to Marcus and Wing 
(1988) a high score is indicated by a score of 27+. Therefore, according 
to the different criteria used, more subjects in the Wing et al. (1989) 
study met the criteria for a severe binge eating problem than in the 
present study. 
Finally, this discrepancy may be due to a sample bias. In the 
Wing study, subjects were participating in a weight control program, 
while the present study surveyed a clinic based population. Many 
researchers, for example deZwaan, Seim et al. (in press) highlight the 
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increased prevalence of eating disordered behaviour in persons who 
attend weight control programs. 
This result is similar to that of Kenardy et al. (1994), who found 
a higher prevalence of binge eating in the diabetic (14%) compared to 
the control (4%) participants. Both the present study and the Kenardy 
et al. (1994) study used a clinical interview as one of their assessment 
measures. Wing et al. (1989) suggested that past studies have relied 
almost exclusively upon self-report measures to determine the 
prevalence of binge eating. They proposed that future studies should 
use clinical interviews, as well as self-report outcome measures to 
increase the reliability and validity of the research. The use of a clinical 
interview in both the present and the Kenardy et al. (1994) study may 
thus indicate a more reliable and valid measure of binge eating 
symptomatology and may partly explain the comparatively lower rates 
of binge eating symptomatology found in these two studies when 
compared to the Wing study. 
One difference however, between the present study and the 
Kenardy et al. study was that Kenardy et al. did not find any evidence of 
binge eating severity amongst the diabetics. One possible explanation 
of this finding is that Kenardy et al. used a sample of newly-diagnosed 
NIDDM patients, and perhaps more severe binge eating problems are 
associated with longer illness duration. A further explanation is that 
overtime, as dietary changes are made, diabetics may feel greater diet 
restriction, which may be associated with a higher incidence of binge 
eating. 
Depressive Symptomatology 
Although a similar number of both the control and diabetic 
participants scored in the non-depressed - moderately depressed range, 
more diabetic than control participants reported moderate-severe 
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depressive symptomatology. Overall, this indicates an increased 
prevalence and severity of depressive symptomatology amongst the 
diabetic participants, thus supporting the hypothesis. 
Much of the literature in this area documents high rates of major 
depression or a significantly increased mean level on depressive 
symptom scales and thus, the results of the present study support this 
general finding. There are several possible underlying mechanisms 
which may explain the association between depression and diabetes. 
Geringer (1990) states that abnormalities in the hypothalamic-
pituitary adrenocortical axis, particularly cortisol response, is common 
to diabetes and depression. Furthermore, Hudson et al. (1984) indicate 
that diabetic individuals without depression, and depressed non-
diabetic individuals show the same abnormal response to 
dexamethasone suppression tests. In addition, a further possible 
explanation is neurotransmitter functioning. In particular, 
norepinephrine and serotonin deficiencies have been implicated in both 
depression and animal models of diabetes (MacKenzie & Trulson, 1978). 
Overall, this research suggests that particular neuroendocrine and 
physiological mechanisms may be mediating factors in the relation 
between depression and diabetes. 
In addition, there are a number of psychosocial factors that may 
explain the relationship between depression and diabetes. For example, 
Peyrot and Rubin (1989) and Palinkas et al. (1991) suggest that coping 
styles and self-efficacy and awareness of their diabetic condition may all 
mediate the relationship between depression and diabetes. 
Furthermore, possible relationship problems may arise as a result of 
the adjustment to diabetes (Robinson et al. 1988) which may result in 
feelings of depression. Thus, it is possible that these factors may in 
part explain the relationship between depression and diabetes found in 
the present study. 
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Relation between binge eating and depressive symptomatology 
As was indicated by the results, the BDI and BES total scores 
were significantly correlated for both control and diabetic participants, 
suggesting an association between binge eating and depressive 
symptomatology. Furthermore, depressive symptomatology severity 
was found to be associated with binge eating symptomatology severity, 
for the diabetic participants only. 
Many researchers have found an association between binge eating 
and depression (Wing et al. 1989, Hudson et al. 1988 & Spitzer et al. 
1993). Furthermore, Marcus et al. (1992) found that both current and 
lifetime major depression was common in type II diabetic patients 
entering a weight control program. Therefore, the results of the present 
study support this literature. 
Although the association between binge eating and depressive 
symptomatology exists, explanations for this association remain 
unclear. It has been suggested that depressive symptomatology occurs 
secondary to binge eating (Cooper & Fairburn, 1986). Alternatively, 
many researchers suggest that binge eating occurs secondary to 
depressive symptomatology (Pope & Hudson, 1988). Furthermore, 
recent work suggests that the association between binge eating and 
depressive symptomatology is mediated by other variables (Wing et al. 
1989). 
Due to the nature of the present study, it is not possible to 
ascertain the causal nature of binge eating and depressive 
symptomatology. It is possible, in the present study, that binge eating 
and depressive symptomatology may be mediated by the presence of 
diabetes, or at least diabetes-specific factors (for example, diabetic 
complications, higher body weight, taking medication that may increase 
weight and difficulty losing weight due to diabetes-specific medication). 
This is perhaps evidenced by the significant association found between 
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binge eating and depressive symptomatology severity, for the diabetic 
participants only. 
This association between severity of binge eating and depressive 
symptomatology may be due to a possible focus, in the diabetic 
participants, on dietary and body weight issues. This is a necessary 
part of their diabetes management, but may result in them becoming 
preoccupied with weight and hold rigid attitudes about dieting 
(Williamson et al. 1985; deZwaan et al. 1994) and experiencing more 
diet-related cognitions and behaviour(s) (Marcus, Wing & Hopkins, 
1988), than their control counterparts. In support of this, Kenardy et 
al. (1994) found that their population of NIDDM patients experienced 
more cognitive restraint in relation to their eating behaviour(s) than the 
control group. 
Furthermore, it has been reported by Bruce & Agras ( 1992) that 
emotion-based dimensions, such as feelings of depression and 
loneliness may trigger binge eating episodes. Feelings of guilt and 
frustration may be experienced by diabetic women in relation to their 
dietary and eating patterns. Furthermore, greater body weight and 
shape dissatisfaction was reported by the diabetic women, which may 
result in feelings of depression. In addition, a greater prevalence of 
depressive symptomatology was reported in the diabetic group. As such 
feelings have been found to trigger binge eating episodes (Bruce & 
Agras, 1992), this may explain why binge eating is more prevalent in the 
diabetics, and may elucidate further the association between binge 
eating and depressive symptomatology often evident in diabetics. 
Hypothesis Two 
Hypothesis two aimed to evaluate the extent to which dieting and 
dieting behaviour (for example, insulin purging and use of laxatives and 
vomiting, for weight-related purposes) occurs in a clinic population of 
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women with type II diabetes. It was hypothesised that the diabetic 
population would indicate more dieting and dieting behaviour than the 
control population. This hypothesis was partly supported by the 
present study. 
Satisfaction with current weight and body shape 
The results of the present study indicate that more diabetics than 
controls are dissatisfied with their current weight and body shape, and 
more controls than diabetics are satisfied with their current weight and 
body shape. Those that indicate concerns regarding their current 
weight and body shape, in both the control and diabetic groups, 
reported a desire to decrease body weight. Furthermore, many of the 
diabetic participants also felt that diabetes and diabetes-specific 
medication affects their weight, in particular by increasing it. 
Overall, these findings may be partly explained by the social 
pressures encouraging women to be thin and to diet to achieve this 
ideal (Heins & Beebe, 1992; Stancin et al. 1989). Feelings of guilt may 
be experienced by the diabetic woman when failing to maintain her 
recommended diabetic diet, and thus dissatisfaction with her weight 
and body shape may result. Furthermore, frustration may also be 
experienced by those diabetic women who feel that diabetes and 
diabetes-specific medication increases their weight, thus making weight 
loss more difficult. In addition, as obesity is a risk factor for the 
development of diabetes (Moore, 1995), and higher body weights were 
reported by the diabetic participants, the diabetic group may thus 
experience greater social and health pressures to maintain a healthy 
body weight and become dissatisfied if this does not occur. 
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Dieting and dieting behaviour 
The diabetics indicated a higher rate of dieting than the controls, 
however this result was not significant, and thus only partly supporting 
the hypothesis that the diabetic participants would evidence greater 
dieting behaviour than the controls. The diabetic participants also 
reported both significantly greater lowest and highest BMI and greater 
weight fluctuations than the control group. 
Overall, there does appear to be associations between the 
presence of a dieting history, binge eating and weight fluctuations 
within the diabetic group. Firstly, although not significantly, a trend 
towards more dieting was highlighted in the diabetic group. Secondly, 
more binge eating behaviour was reported, and thirdly, greater weight 
fluctuations were also indicated amongst the diabetic participants. 
There are several possible explanations and underlying mechanisms 
which may explain these associations. 
Firstly, these results are consistent with the notion of biologically 
derived adaptations secondary to dietary restraint, which may facilitate 
weight gain. Wardle (1987) suggests that dietary restraint results in 
biologically sub-optimal weight. Subsequent binge eating is seen as an 
attempt to restore body weight to a more biologically appropriate level 
(Herman & Polivy, 1990). 
A further possible explanation is suggested by Telch et al. (1988). 
They propose that weight cycling is involved with repeated dieting, 
which may lead to weight gain, weight fluctuation and binge eating. In 
addition, 'binge food' is often high in carbohydrates and fat content 
(Bulik, 1994), which are types of food that may lead to weight gain. The 
guilt often experienced after a binge episode may result in further 
dietary restriction which may subsequently cause weight loss. It is 
possible that this largely cognitive cycle may explain the association 
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between dieting, binge eating and weight fluctuation found in the 
diabetic group. 
There was no reported difference between the groups in relation 
to diet pill use, vomiting, and exercise for weight related purposes 
(weight control and weight loss). This result does not support the 
hypothesis that the diabetic participants would report more diet related 
behaviour than the control group. Similar results have been found by a 
number of researchers (Telch et al. 1988; Hudson et al. 1988, Marcus & 
Wing, 1987, Mitchell et al. 1990) where purging and use of diet pills for 
weight control is less frequent in overweight populations than in normal 
weight binge eaters. The fmdings of the present study may thus 
support the literature regarding purging behaviour(s) in overweight 
populations. These results also suggest that extreme forms of purging 
behaviour are rare among NIDDM populations. 
Diabetes-speeiflc medication self-manipulation 
While the majority (62.3%) of the diabetic participants reported 
altering (decreasing) their medication dosage, this was mainly for 
reasons such as forgetting, and altering dosage according to exercise 
and blood sugar levels. Alteration of medication dosage due to blood 
sugar levels and exercise is common among diabetics and is entirely 
appropriate behaviour. 
However, eight (6.7%) of the diabetic participants reported having 
decreased their recommended dose of medication for weight-related 
purposes. Of the eight, six used insulin, one used tablets and one used 
tablets and insulin to manage their diabetes. In other words, of the 
diabetic participants that used insulin to manage their diabetes, 6 
(11.3%) manipulated their insulin for weight-related reasons. In 
addition, self-manipulation of diabetes-specific medication was also 
associated with the presence of a dieting history. 
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Of the two studies that have addressed binge eating and eating 
disordered behaviour in NIDDM patients, neither have addressed the 
issue of diabetes-specific medication self-manipulation. However, the 
issue of insulin manipulation has been addressed in relation to IDDM 
populations (Striegel-Moore et al. 1992; Fairburn et al. 1991; Birk & 
Spencer, 1989; Rodin et al. 1986-1987; Hudson et al. 1985; Steel et al. 
1987). The rate of insulin-manipulation found in the present study, is 
comparable to many of the IDDM studies, suggesting that it may be as 
common in some NIDDM populations as it is in some IDDM 
populations. 
Among IDDM populations insulin manipulation is associated with 
poorer glycemic control and greater psychological distress and higher 
rates of medical complications (Biggs et al. 1994, Polonsky et al. 1994). 
Such associations were not found in the present study, however with a 
larger sample of NIDDM insulin users such results may be found. 
Overall, these results suggest that although extreme forms of 
purging such as diet pill use, vomiting, and exercise are rare, insulin 
manipulation may be a used as a means of weight control or weight loss 
among NIDDM women, perhaps particularly among those with a 
dieting history. This is a particularly worrisome finding due to the 
known physiological and possible psychological correlates of such 
behaviour. 
Hypothesis Three 
Hypothesis three aimed to establish the relationship between 
variables such as age, binge eating, depressive symptomatology, self-
manipulation of diabetes-specific medication, obesity, glycemic control, 
illness duration, medical illnesses and SMOBG behaviour within the 
diabetic participants. It was predicted that there would be positive 
correlations between binge eating, depressive symptomatology, poorer 
79 
glycernic control, obesity and self-manipulation of diabetes-specific 
medication. This prediction was largely supported. 
Binge eating symptomatology, BMI, highest BMI, range of BMI 
and glycernic control were all found to be correlated, supporting the 
hypothesis. These results suggest that the presence of binge eating 
may be related to body weight, highest body weight and weight 
fluctuation, as is discussed previously. This result is supported by 
literature that claims that binge eating is more prevalent among 
individuals of higher body weight (Telch et al. 1988). 
Furthermore, binge eating appears associated with poorer 
glycernic control in the present study. This is a common finding among 
IDDM populations, yet in the Wing et al. (1989) study binge eating was 
unrelated to weight or glycernic control. This discrepancy may be due 
to the lower BMI average of the diabetic participants in the present 
study. In addition, a further explanation may be the different samples 
used in the two studies. Wing et al. (1989) used a sample of diabetic 
participants recruited from a weight loss program, while the present 
study used a clinic based sample of NIDDM women. It is possible that 
as the sample in the Wing study were attending a weight loss program 
that they may have made some dietary changes to promote weight loss 
that may have also reduced their blood sugar levels. This may partly 
explain why the Wing et al. (1989) study did not find an association 
between binge eating and glycernic control. 
The presence of depressive symptomatology was also found to be 
related to glycernic control, BMI and BMI range. This suggests that 
those with higher body weight and weight fluctuations may experience 
greater depressive symptomatology, as discussed previously. The 
association between poorer glycemic control and depressive 
symptomatology is supported by Lustman et al. (1986) who stated that 
depression in diabetes may either cause or be caused by poor glucose 
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regulation. The reason for this association is still unknown and as 
these results are correlational no causal direction can be posited. 
These results also support the literature stating that those diabetic 
individuals with higher body weight may experience worse glycemic 
control (Moore, 1995). 
Effects of dieting 
Those diabetics with a history of dieting had higher current and 
past body weights, reported greater weight fluctuations, poorer glycemic 
control and reported the presence of at least one current medical 
illness, not associated with diabetes. As is discussed previously, this 
result supports the higher weights and weight fluctuation evident in 
dieters (Telch et al. 1988). This is also supported by the negative 
correlation found between age of first diet and highest BMI, suggesting 
that earlier dieting is associated with higher body weight. Alternatively, 
this result may suggest that children with higher body weight may 
begin dieting earlier than children with lower body weight, perhaps due 
to greater social and health pressures. 
The finding that dieting is related to poorer glycemic control 
among the diabetic group, and that age of the first diet is negatively 
correlated with glycemic control, further support the relation between 
bingeing and dieting, as binge eating was also found to be correlated 
with poorer glycemic control. It is possible that both dieting and 
bingeing may have more extreme effects on diabetics, due to their 
already poorer metabolic control and fluctuating glucose levels. 
Presence of Medical illnesses 
The presence of at least one medical illness among the diabetic 
group was related to current body weight, highest body weight and body 
weight range and the presence of depressive symptomatology. This is 
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supported by the knowledge that weight reduction improves glycemic 
control and health, and thus decreases the possibility of medical 
complications and illness (Moore, 1995). 
In relation to the association between medical illnesses and 
depressive symptomatology, Lloyd et al. (1992) acknowledge the poorer 
quality of life experienced by those individuals with concurrent diabetes 
and other medical problems. Quality of life was shown to deteriorate for 
those with more than one additional medical illness. In addition, as 
was discussed previously, possible physiological and/ or neurological 
abnormalities may be common to both diabetes and other medical 
illnesses. 
lllness Duration 
Finally, there appears to be an association between illness 
duration and glycemic control, suggesting that a longer illness duration 
leads to poorer glycemic control. This is supported by the finding that 
over the long term, due to many factors including poorer glycemic 
control, diabetes increases the possibility of damage to the eyes, 
kidneys, feet and heart (Moore, 1995). 
4.2 Strengths of the present study 
A number of methodological limitations exist in the diabetes 
literature and the literature addressing eating disordered and 
depressive symptomatology in diabetes (Rubin & Peyrot, 1992). Firstly, 
samples are often not representative of the diabetic population at large. 
Secondly, outcome measures are often absent and frequently poor, 
such as self-report measures regularly used as the sole outcome 
measure. Wing et al. (1989) highlight the need for the use of clinical 
interviews, as was discussed previously. Furthermore, the design of 
most studies is seriously flawed, often not including control groups. 
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Some studies have also failed to distinguish between type I and II 
diabetes and, as has been highlighted, differences between these two 
populations can be profound. Finally, there are often diagnostic 
inconsistencies between studies. 
In the present study several of these methodological problems 
were considered. Firstly, as the sample was a clinic based population of 
NIDDM women, the present study provides worthwhile information for 
clinicians working with diabetic patients. 
Secondly, a semi-structured clinical interview was used 
concurrently with the BES and BDI self-report measures, overcoming 
the sole-use of self-report assessment measures and perhaps increasing 
the reliability and validity of the study. A further strength of the 
present study is the use of the BES, which assesses not only 
behavioural manifestations of binge eating, but also evaluates 
cognitions, such as the abstinence violation effect, that are particularly 
relevant to binge eating. 
Furthermore, a control group was used that was matched by age, 
sex and to some degree social class. Wacholder et al. (1992) evaluated 
the use of friends as controls and a number of advantages were 
highlighted. Friends of cases may be a more convenient and 
inexpensive source of controls than other alternatives. They may also 
be matched on several variables, such as use of the medical system in 
similar ways. Moreover, biases due to social class are reduced since 
usually the case and friend control will be of a similar socioeconomic 
background. 
Moreover, only type II diabetic patients were recruited. In 
addition, the present study was not diagnostic as such, rather 
evaluated the presence of binge eating and depressive symptomatology. 
Finally, a reliability check was conducted on the coding and entering of 
the data, increasing the reliability of the findings. 
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4.3 Limitations of the present study 
However, regardless of the methodological considerations outlined 
above, there are still a number of limitations to the present study. 
Firstly, with regards to the population sampled, the results of this study 
cannot be generalised to all diabetic patients as a clinic based sample is 
not representative of all diabetic groups for many reasons, including the 
possibility that those diabetics attending a clinic may do so as that have 
more severe diabetes or additional complications. Similarly, as only 
women were sampled these results cannot be generalised to male 
populations. In addition, due to the voluntary nature of recruitment, 
many of those diabetic patients that experience eating disordered 
and/ or depressive symptomatology, or those that may be sensitive to 
these topics, may have selected themselves out. This selection bias may 
have been evident in the participation rate of 68.4%, in other words, 
32.6% of those eligible did not participate. 
Questions related to weight and appetite were omitted from the 
BDI in the Wing et al. (1989) study, firstly to control for BDI scores 
possibly being influenced by weight and appetite factors and secondly, 
factors such as weight, appetite, body image and satisfaction and eating 
behaviour were assessed using the BES. Such omission was not 
undertaken in the present study and therefore BDI scores in the 
present study may have been influenced by weight and appetite factors. 
Furthermore, Kenardy et al. (1994) screened control subjects' 
blood glucose levels to detect any possible elevations. Kenardy et al. 
(1994) also screened all participants (diabetic and controls) for alcohol 
problems, as alcohol has been reported to disinhibit individuals' eating 
(Polivy & Herman, 1976). Neither of these screenings were conducted in 
the present study. Therefore possible alcohol usage was not known 
and, if used, alcohol may have disinhibited participants eating, 
resulting in higher binge eating symptomatology. 
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In relation to the assessment measures used in this study, the 
semi-structured questionnaire, designed specifically for the purposes of 
this study, although piloted on six women prior to testing, was not 
standardised nor validated. Furthermore, the BDI and BES, although 
both highly standardised and validated, are not diagnostic instruments, 
thus the rates of depressive and eating disordered symptomatology 
reported in the present study are only indications of the presence and 
severity of these behaviours and cannot be considered conclusive. 
In addition, no normative data or established cut-off scores exist 
for the BES, for example the BES has no established cut-off scores to 
indicate a mild binge eating problem (Wing et al. 1989). Further still, 
the BDI gives a reliable and valid indication of depressive 
symptomatology over the last two weeks only, consequently indicating 
only current rather than lifetime prevalence of depressive 
symptomatology. 
With regards to the use of 'friends as controls', Wacholder et al. 
(1992) also state that they have a number of reservations about the use 
of 'friends as controls'. Namely, the sampling may be biased as sociable 
people (case and friend) are more likely to be selected for recruitment, 
than are loners. In the present study, this could have been evident by 
the number of the diabetic participants who refused. However, those 
diabetic participants that did volunteer were invited to bring a friend (to 
be a control participant), however, were not selected on this premise. In 
other words, if a consenting diabetic participant did not have a friend to 
bring, we still recruited the diabetic participant regardless. This may 
have eliminated some of the bias. 
A further possible shortcoming of using friends as controls is the 
possibility of overmatching, since friends tend to be similar with regard 
to lifestyle and occupational exposures of interest (Wacholder et al. 
1992). In the present study we were primarily interested in dieting 
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behaviour, disordered eating behaviour, such as binge eating, and 
depressive symptomatology. As dieting and eating disordered behaviour 
tend to be more prevalent among obese populations (deZwaan et al. 
1994), and use of friends as controls often reduces the bias of social 
class, it may be possible that many of the diabetic women had obese 
friends that may have shared similar lifestyles including dieting and 
eating behaviour. This may have biased the findings of the present 
study. 
A further limitation of this study concerns correlational statistics. 
Although correlational statistics are useful to ascertain a possible 
relation between variables, a correlation does not imply causality. 
Thus, the causal nature of many of the associations highlighted in this 
study cannot be addressed. Longitudinally designed research is 
necessary to address these issues. 
4.4 Conclusions and future research 
Conclusions 
The results of the present study suggest that binge eating is both 
more prevalent and severe among type II diabetic women than among 
control women, although not as prevalent as that reported in the Wing 
et al. (1989) study. Current depressive symptomatology was also more 
prevalent among the diabetic group. An association was found between 
binge eating and depressive symptomatology, and for the severity of 
binge eating and depressive symptomatology among the diabetics only. 
Dieting was not significantly more prevalent among the diabetic 
group, however diabetics indicated greater dissatisfaction with their 
current weight and body shape, perhaps due to factors such as 
frustration and increased social and health pressures. Diabetics did 
not use diet pills, vomiting and exercise, for weight-related reasons, 
significantly more than the controls, however, insulin manipulation was 
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reported in numbers comparable to many of the IDDM studies. This 
finding suggests that although extreme forms of dieting and purging 
behaviour, such as diet pill use and vomiting are not common, insulin 
manipulation may be used among NIDDM women for weight-related 
reasons. Associations were found between. dieting, binge eating 
symptomatology, depressive symptomatology, poor glycemic control, the 
presence of medical illness and weight fluctuations in the diabetic 
group. 
Overall, these results suggest that dieting and bingeing behaviour 
may have a more detrimental effect on diabetic women due to their 
already poorer metabolic control and fluctuating glucose levels. There 
is also strong evidence that these behaviours may result in a poorer 
emotional and physical quality of life among NIDDM women. Thus, 
clinicians working in this field should be aware of these behaviours, and 
their effects, among women with NIDDM. 
Future Research Areas 
The field of type II diabetes and eating disordered behaviour is 
still in its infancy and as such much research is necessary. However, 
several primary areas are worthy of prompt future consideration. As 
has been highlighted, self-manipulation of diabetes-specific medication 
in NIDDM occurs at a rate worthy of concern and as such the practice 
of self-manipulation of medication in NIDDM requires much future 
research attention. Furthermore, as has been noted by many 
researchers the current assessment tools do not address the issue of 
self-manipulation of diabetes-specific medication. The development of a 
tool that measures such behaviour is therefore necessary to assessing 
the full extent of this behaviour. 
As is discussed, some interesting work has been conducted 
addressing the physiological and neurological correlates and 
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associations between depression and diabetes. This appears promising, 
and further research in this area should continue. 
In the present study an association was found between binge 
eating and depressive symptomatology, yet the causal nature of this 
relationship is still poorly understood. Longitudinally designed 
research studies may be necessary to further address the issue . 
. In terms of the generalisability of these research findings, the 
findings of the present study suggest cross-cultural differences in the 
rate and severity of binge eating and depressive symptomatology. 
However, it is not known whether these results will translate to other 
cultures. Cross-cultural research in this field, as in many, is strongly 
lacking and is certainly an area worthy of future attention. Finally, due 
to the female to male ratio of both eating disordered behaviour and 
depressive symptomatology, it is obvious why such research has taken 
a female subject focus, yet, further research into these areas using male 
samples is also needed. 
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APPENDIX A 
INFORMATION AND CONSENT FORMS - DIABETIC 
PARTICIPANTS 
INFORl\.1ATION SHEET 
HEALTH AND PSYCHOSOCIAL ISSUES FOR WOI\1EN WITH 
MATURITY ONSET DIABETES 
A recent survey of women with insulin-dependent diabetes in North Canterbury 
indicated that, for many, eating, weight control and women's health concerns are 
important issues. There is, however, very little information available about these issues 
for women with maturity onset diabetes. 
This survey is to learn more about the concerns that women with maturity onset 
diabetes have regarding eating, weight control, mood, menstruation and contraception. 
We want to compare how women with and without diabetes feel about these issues. This 
information will help us deliver a better service to women with maturity onset diabetes, 
in the future. 
If you choose to take part in this study, a time will be arranged for Anita or Marie to 
meet with you for one interview at the Diabetes Centre. You are invited to bring a 
friend who will be interviewed to help find out how women without diabetes feel about 
these issues. The interview is likely to take less than one hour. Participation in the 
survey will be free and transpo1i will be arranged, if required. 
After the interview, there will be some questionnaires to fill out about eating and mood, 
your height and weight will be measured, and a finger-prick blood sample will be taken 
for a glycated haemoglobin. (Your friend would not have a finger-prick done). All 
participants will receive a written summary of the survey findings. 
If you agree to participate in the survey, your name and identity will be kept 
confidential, i.e. your answers will be anonymous. With your consent, your General 
Practitioner will be informed of your participation, and of your blood test result. If you 
choose not to take part, this will not affect your future treatment at the Diabetes Centre 
in any way. Thank you for your help and co-operation. 
ANITA STROUD 
Summer Research Student 
MARIE 'WEBSTER 
Summer Research Student 
PHILIPPA CAMPBELL-TIE 
Clinical Psychologist/Diabetes Centre 
HELEN LUNT 
Diabetes Physician/Diabetes Centre 
SOUTHERN REGIONAL HEAL TH AUTHORITY ETHICS COMMITTEE 
(Canterbury) {SRHA) 
HEAL TH AND PSYCHOSOCIAL ISSUES FOR WOMEN WITH 
l'{IATURITY ONSET DIABETES. 
I have read the information sheet and have had the opportunity to discuss this 
study with my family and/or doctor. I understand that it has been approved by the 
Southern Regional" Health Authority Ethics Committee. 
I understand that participation is confidential (ie anonymous), and that no 
information will be disclosed without my permission, unless the failure to disclose 
information would jeopardise my safety, · 
I understand that I may withdraw from the study at any time, and for any reason, 
without adversely affecting present or future treatment. 
Signature of Participant: __________ _ Date: -------
Signature of Investigator: __________ _ Date: -------
Signature of Witness: Date: -------
APPENDIXB 
INFORl\11.ATION AND CONSENT FORMS - CONTROL 
P ARTICIP Al'iTS 
INFORMATION SHEET 
HEALTH AND PSYCHOSOCIAL ISSUES FOR WO:MEN WITH 
MATURITY ONSET DIABETES 
A recent survey of women with insulin-dependent diabetes in North Canterbury 
indicated that, for many, eating, weight control and women's health concerns are 
important issues. There is, however, very little information available about these issues 
for women with.maturity onset diabetes. 
This survey is to learn more about the concerns that women with maturity onset 
diabetes have regarding eating, weight control, mood, menstruation and contraception. 
We want to compare how women with and without diabetes feel about ~hese issues. This 
information will help us deliver a better service to women with maturity onset diabetes, 
in the future. 
We would like to interview you to find out how women without diabetes feel about these 
issues so that we can compare your answers with those of women who have diabetes. 
If you choose to take part in this study, a time will be arranged for Anita or lVIarie to 
meet with you for one interview at the Diabetes Centre. The interview is likely to take 
less than one hour. Participation in the survey will be free and transport will be 
arranged, if required. 
After the interview, there will be some questionnair~ to fill out about eating and mood, 
and your height and weight will be measured. All participants will receive a written 
summary of the survey findings. 
If you agree to participate in the survey, your name and identity will be kept 
confidential, i.e. your .lffiwers will be anonymous. H you choose not to take part, this 
will not affect your future treatment by Canterbury Health in any way. Thank you for 
your help and co-operation. 
ANITA STROUD 
Summer Research Student 
MARIE WEBSTER 
Summer Research Student 
PHIT.,IPPA CA1\1PBELL-TIE 
Clinical Psychologist/Diabetes Centre 
HELEL~ LUNT 
Diabetes Physician/Diabetes Centre 
SOUTHERN REGIONAL HEAL TH AUTHORITY ETHICS COMMITTEE 
(Canterbury) (SRHA) 
HEAL TH AND PSYCHOSOCIAL ISSUES FOR WOMEN WITH 
MATURITY ONSET DIABETES 
I have read the information sheet and have had the opportunity to discuss this 
study with my family and/or doctor. I understand that it has been approved by the 
Southern Regional Health Authority Ethics Committee. 
I understand that participation is confidential (ie anonymous), and that no 
information will be disclosed without my permission, unless the failure to disclose 
information would jeopardise my safety. 
I understand that I may withdraw from the study at any time, and for any reason, 
without adversely affecting present or future treatment. 
Signature of Participant: __________ _ Date: ______ _ 
Signature of Investigator:---'------------ Date: ______ _ 
Signature of Witness: Date: -------
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111 Date: ,.A. TT 
!I:~•-· 
~::::~;~=====~==:-===--Mw:itaf"Status: ______ Age: ____ Sex: ___ _ 
~- Education: ___________________ _ 
uestionnaire consists of 21 groups of statements. After reading each group of statements carefull: 
the number (0, 1, 2 or 3) next to the one statement in each group which best describes the way yo· 
eeh feeling the past week. including today. If several statements within a group seem to apply equall. 
ircle each one. Be sure to read all the statements in each group before making your choice. 
I do not feel sad. 
I feel sad. 
I a._rn·sad all the time and I can't snap out of it. 
lam so sad or unhappy that I can't'stand it. 
I am not particularly discouraged about the 
future. 
Heel discouraged about the future. 
I feel I have nothing to look forward to. 
l feel that the future is hopeless and that 
things cannot improve. 
I do not feel like a failure. 
I feel I have failed more than the 
average person. 
As I look back on my life, all I can see is 
a lot of failures. 
If eel I am a complete failure as a person. 
I get as much satisfaction out of things as I 
used to. 
I don't enjoy things the way I used to. 
I don't get real satisfaction out of anything 
anymore. 
I am dissatisfied or bored with everything. 
I don't feel particularly guilty. 
I feel guilty a good pa17t of the time. 
I feel quite guilty most of the time .. 
I feel guilty all of the time. 
I don't feel I am being punished. 
I !eel I may be punished. 
I expect to be punished. 
I !eel I am being punished. 
I don't feel disappointed in myself. 
I am disappointed in mysel!. 




















I don't feel I am any worse than 
anybody else. 
I am critical of myself for my weaknesses 
ormistakes. _ _ 
I blame myse~ all the time for my faults. 
I blame myself for everything bad 
that happens. 
I don't have any thoughts of killing myself. 
I have thoughts of killing myself, b1:,1t I 
would not carry them out. 
I would like to kill myself. 
I would kill myself if I had the chance. 
I ~on't cry any more than usual. 
I cry more now than I used to. 
I cry all the time now. 
I used to be able to cry, but now I can't cry 
even though I want to. 
I am no more irritated now than I ever am. 
I get annoyed or irritated more easily than 
I used to. · 
. . 
I feel'irritated all the time now. 
I don't get irritated at all by the things that 
used to irritate me. 
I have not lost interest in other people. 
I axn less interested in other people than 
·I.used to be. 
I have lost most of my interest in 
other people. 
I have lost all of my interest in other people. 
I make decisions about as well as 
I ever could. 
I put off making decisions more than 
I used to. · 
I have greater difficulty in making 
decisions than before. 
I can't make decisions at all anymore. 
___ Subtotal Page 1 CONTINUED ON BAC 
(m\THE l'$YCHCltX,l<.:AL Cl.lRl'(lRATK1N 
Q;/HARC"lXJRT flRACI: J( 'l'v.-\Nl.lVl<..J-1. INC. 
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NOTICE: II is :igainsl the law 10 photocopy or ot11crw1se reproduce 
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I don't feel I look any worse than I used to. 
I am worried that I am looking old or 
unattractive. 
I feel that there are permanent changes 
in my appearance that m.ak.e me look 
unattractive. · 
I believe that I look ugly. 
I can work about as well as before. 
It takes an extra effort to get started at 
doing something. 
I have to push myself very hard to do 
anything. 
I can't do any work at all. 
I can sleep as well as usual. 
I don't sleep as well as I used to. 
I wake up l ·2 hours earlier than usual 
and find it hard to get back to sleep. 
I·wake up several hours earlier than I 
used to and cannot get back to sleep. 
I don't get more tired than usual. 
I gettired more easily than I used to. 
I get tired from doing almost anything. 
I am too tired to do anything . 
. My appetite is no worse than usual. 
My appetite is not as good as it used to be. 
My appetite is much worse now. 
I have no appetite at all anymore. 
19 fl i ha:ven't lost much weight, :if any, lately. 
I have lost more lhan 5 pounds. 
. , I have lost more than 10 pounds . 
:1 I have lost more than 15 pounds. 
I am purposely trying to lose weight by 
eating less. Yes No 
2U I am no more worried about my health 0 
than usual. 
I am worried about physical problems 
such as aches and pains: or upset 
stomach; or constipation. .. I am very worried about physical 
problems and it's hard to think of 
much else. 
:1 I am so worried nbout my physical 
problems that I cannot think about 
anything else. 
21 u I have not noticed any recent change. 
in my interest in sex. 
I am Jess interested in sex than I used 
to be. 
. , I am much less interested in sex now . 
:i I have lost interest in sex completely. 
___ Subtotal Page 2 
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APPENDIXD 
BINGE EATING SCALE (BES) 
Eating Habits Checklist 
Instructions. Below are groups of numbered statements: Read all of the statements _in 
each group and mark on this sheet the one that best describes the way you feel about 
any problems you have controlling your eating behaviour. 
#1 
1. I don't feel self-conscious about ny weight or body size when I'm with others. 
2. I feel concerned about how I look to others, but it nonnally does not make me 
feel disappointed with myself. 
3. I do get self-conscious about my appearance and weight which makes me feel 
disappointed in myself. 
4. I feel very self-conscious about my weight and frequently, I feel intense shame 
and disgust for myself. I try to avoid social contacts because of my self-
consciousness. 
#2 
1. I don't have any difficulty eating slowly in the proper manner. 
2. Although I seem to 11 gobble down 11 foods, I don't end up feeling stuffed because 
of eating too much. 
3. At times, I tend to eat quickly and then 1 feel uncomfortably full afterwards. 
4. I have the habit of bolting down my food without really chewing it. When this 
happens I usually feel uncomfortably stuffed because I've eaten too much. 
#3 
1. I feel capable of controlling my eating urges when I want to. 
2. I feel as though I have failed to control my eating more than the average person. 
3. I feel utterly helpless when it comes to feeling in control of my eating urges. 
4. Because I feel so helpless about controlling my eating I have become very 
desperate about trying to get in control. 
#4 
1. I don't have the habit of eating when I'm bored. 
2. I sometimes eat when I'm bored, but often I'm able to 11 get busi' and get my 
mind off food. 
3. I have a regular habit of eating when I'm bored but occasionally, I can use some 
other activity to get my mind off eating. 
4. I have a strong habit of eating when I'm bored. Nothing seems to help.me break 
the habit. 
#5 
1. Pm usually physically hungry when I eat something. 
2. Occasionally, I eat something on impulse even though I really am not hungry. 
3. I have the regular habit of eating foods that I might not really enjoy to satisfy 
a hungry feeling even though physically I don't need the food. 
4. Even though I'm not physically hungry, I get a hungry feeling in my mouth that 
only seems to be satisfied when I eat food, like a sandwich, that .fills my mouth. 
Sometimes, when I eat the food to satisfy my mouth hunger, I then spit the food 
out so that I won't gain weight. 
#6 
1. I don't feel any guilt or self-hate after I over-eat. 
2. After I over-eat, occasionally I feel guilt or self-hat~. 
3. Almost all the time, I experience strong guilt or self-hate after I over-eat. 
#7 
1. I don't lose total control of my eating when dieting, even after periods when I 
over-eat. 
2. Sometimes, wh~n I eat a 11 forbidden food" on a diet, I feel like I "blew it 11 and 
eat even more. 
3. Frequently, I have the habit of saying to myself, "I've blown it now, why not go 
all the wai1 when I over-eat on a diet. ·when that happens, I eat even more. 
4. I have a regular habit of starting strict diets for myself, but I brea;I< the diets by 
going on an eating bi:r:ige. My life seern_s to be either 11 a feast or a' famine 11 • 
#8 
1. I rarely eat so much food that I feel uncomfortably stuffed afterwards. 
2. Usually, about once a month, I eat such a quantity of food that I end up feeling 
very stuffed; 
3. I have regular periods during the month when I eat large amounts of food, either 
at meal-times or at snacks. 
4. I eat so. much food that I regularly feel quite uncomfortable after eating, and 
sometimes·a bit nauseous. 
#9 
1. My level of calorie intake does not go up very high or go down very low on a 
regular basis. 
2. Sometimes, after I over-eat, I will try to reduce my caloric intake to almost 
nothing, to compensate for the excess calories I've eaten. 
3. I have a regular habit of over-eating during the night. It seems that my routine 
is not to be hungry in the morning, but to over-eat in the evening. 
4. In my adult years, I have had week-long periods where I practically starve 
myself. This follows periods when I over-eat. It seems I live a life of either 
11 feast or famine. 11 
#10 
1. I usually am able to stop eating when I want to. I know when 11 enough is 
enough. 11 
2. Every so often, I experience a compulsion to eat which I can't seem to control. 
3. Frequently, I experience strong urges to eat which I seem unable to control, but 
at other times, I can control my eating urges. 
4. I feel incapable of controlling urges to eat. I have a fear of not being able to 
stop eating voluntarily. 
#11 
1. I don't have any problem stopping eating when I feel full. 
2. I usually can stop eating when I feel full, but occasionally over-eat, leaving me 
feeling uncomfortably stuffed. 
3. I have a problem stopping eating, once I start, and usually I feel uncomfortably 
stuffed after I eat a meal. 
4. Because I have a problem not being able to stop eating when I want to, I 




1. I seem to eat as pmch when I'm with others (family, social gatherings), as' when 
I'm by myself. 
2. Sometimes, when I'm with other people, I don't eat as much as I want to eat 
because I'm self-conscious about my eating. · 
3. Frequently, I eat only a small amount of food when others are present because 
I'm very embarrassed about my eating. 
·. 4. I feel so ashamed about over-eating that I pick times to over-eat when I know no-
one will see me. I feel like a II closet eater. 11 
#13 
1. I eat three meals a day with only an occasional between-meal snack. 
2. .I eat three meals a day but I also normally snack between meals. 
3. When I am snacking heavily, I get into the habit of skipping regular meals. 
4. · There are regular periods when I seem to be continually eating, with no planned 
meals. 
#14 
1. I don't think much about trying to control unwanted eating urges. 
2. At least some of the time, I feel my thoughts are preoccupied with trying to 
eontrol my eating urges. · 
3. · I feel that frequently I spend much time thinking about how much I ate or about 
trying not to eat any more. 
4. It seems to me that most of my waking hours are preoccupied by thoughts about 
eating or not eating. I feel like I'm constantly struggling not to eat. 
#15 
1. I don't think about food a great deal. 
2. I have strong cravings for food but they last only for brief periods of time. 
3. I have days when I can't seem to think about anything else but food. 
4. i\'Iost of my days seem to be preoccupied with thoughts about food. I feel like I 
live to eat. 
#16 
L I usually know whether or not I'm physically hungry. I take the right portion 
of food to satisfy me. 
2. Occasionally, I feel uncertain about knowing whether or not I'm physically 
hungry. At these times it's hard to know how much food I should take to satisfy 
me. 
3. Even though I might know how many calories I should eat, I don't have any idea 
of what a 11 normal 11 amount of food is for me. 
APPENDIXE 
SEMI-STRUCTURED INTERVIEW SCHEDULE -
DIABETIC PARTICIPANTS 
.. 
WOMEN'S ISSUES JN NON-INSULIN-DEPENDENT -DIABETF.S 
(I want to talk~ you TWW ahold eating, dieting and weight amtrol., and heclth ·issues· 
for women., such as menstroat:wn and coTttro.ception. I am interested in. your experience 
and opinions of these things). · 






HbA1c!Random Blood Glucose I 
Year of Diagnosis I 
I Other Merlical Conditions 
I 
', 




1. ~ve you eYer been in hospital for your diabetes? 
(If Yes) What was the reas-0n? (Diagnosis, name of hospital what year?) 
2. Do yon check your own blood sugar leyeJs? 
(If Yes) How often do yon checlc them? (Times per day, days per week?) 
How often have yon chedred your blood sugar leYels in the last week? 





,/ .., -. 
EATING PATfERNS 
l(a) What is the lowest weight you have been since you were 18 years old? 
l(b) What is the highest weight you have been since you were 18 years old? 
l(c) How satisfied are you with your current weight and body shape? 
VERY/MODERATELY/NOT 
(If not moderately satisfied) What concerns do you have about your weight and 
shape? 
2. Have you ever changed your eating patterns or 11 beeri on a diet 11 to try to lose 
weight? (If Yes) At what age did you first diet? (Go to Question 3). (If No, go 
to Questlon 7). 
3(a) . How many times in the last year (since Christmas 1993) have you changed your 
eating patterns or II dieted11 to tose weight? (If no diets in lp.st year, go to Question 
7). 
3(b) During the last year, what was the longest and shortest length of time you spent 
on a diet(s)? (Currently on a diet?) 
4. During the diet(s), what types of changes did you make to your eating patterns? 
(Specify frequency/amount/type of food or drink) 
5(a) When you were II dieting", what was your goal weight? 
·s(b) Did the changes result in any weight loss? (How much weight lest and for how 
long?) 
S(c) Overall, is your weight any different to what it was a year ago? 
(If Yes, how?) 
' ...... - .. ~ .... -... -~ _...., __ ,. .. _____ . . . . .... 
/ 
.. .. _. _ ..,,., •··----··• .,_ .. ,_ .... _~_......_,,.L 
..... 
,,· . .. 
6. Did you notice your blood sugars going low on a diet? If so, how did you know 
your blood sugars were low? (That is, s:;mptoms/SMOBG). What did you do 
about it? 
7. Are you worried that your blood sugars may go too Jow if you diet'? 
(If Yes) Does this affect your approach to dieting? 
(If not currently dieting) A.re there any particular worries or reasons which stop 
you from dietipg? 
I 
I 
8. Have you e-ver seen a dietitian? (When/how often?). 
(If No), go to Question 9. (If Yes), When was the last time you saw a 
dietitian? 
How helpful was this last appointment? (NOT/MODERATELY/VERY) 
In what way was the last appointment unhelpful/moderately helpful/very helpful? 
What changes to your eating :patterns did the dietitian recommend? 
Which of these are you doing now? 
i 
Wbat has stopped you from making the other changes that were recommended? 
Would it be helpful to see a dietitian again? 
YES/NO/PERHAPS/DON'T KNOW. If unhelpful, why? 
9. Do you think that having diabetes would affect a person's weight? YES/NO . . 
,(If Yes) In what way? 
I 
lO(a) Are you on tablets or insulin to help control your blood sugars? 
If no oral hypoglycaemics/insulin, go to Question 16. 
(If Yes) '\Vhat is the name of _the tablets? /Wnat sort of insulin are you taking? 
lO(b) What is your recommended dose for these tablets/the insulin? 
Number/Units? Frequency? 
11. What dose of the tablets/insulin are you actually taking at present? 
(Note any variation from recommended dose) 
(Sometimes miss out on taking tablets/insulin?) 
(If different to recommended dose) Why do you not always take the recommended 
dose? 
,- .·~ '• ------,-
12.. Do you think that your diabetes tablets/insulin affect your weight? 
(If Yes) How do they affect your weight? JN~ASE/DECREASE 
13. Have you ever thought about altering the dose of your diabetes tablets/insulin to 
change your shape or weight? If No, go to Question 16. 
(If Yes) What ha-ve you thought .of doing? IN"CREASEIDECREASE 
14(a) Have you ever actually altered the dose of your diabetes tablets/insulin to try to 
change- your shape or weight? (INCREASE/DECREASE/ A.t'\1OUNT) 
(If Yes, to 14.,(b); If No, to 14 (c). 
14(b) Did you tell your doctor you altered the dose of your tablets/insulin to change 
your shape or weight? 
(To Question 15) 
14(c) 11 Wbat made you decide not to alter your tablets/insulin? 
(To Question 16) 
15. Have you altered the dose of your diabetes tablets/insulin to change your shape 
or weight in the last month? 
(If Yes) How many times have you changed your tablets/insulin in the last 
month? 
By what amount? 
16. Are there any other ways you have tried to control weight, get rid of food you 
had eaten, change your body's shape? (Exercise, pills, vomiting?) 
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WOi\:fEN"'S ISSUES IN NON-JNSULIN-DEP.END~. DIABETES 
(I want w tdJi -with you now ti4out eating, dieting and °W£I'ight conrrol., and health issues 
for women such as menstn.urtion and controception. I cmz interested iii your experience 
and·opi.n.ums of these things). 












l(a) What is the lowest weight you have been since you were 18 years old? 
l(b) What is the highest weight you have b~n since you were 18 years old? 
l(c) How satisfied are you with your current weight and body shape? 
VERY/MODERATELY/NOT 
(If not/moderately satisfied) "What concerns do you have about your weight and 
shape? 
2. Have you ever changed your eating patterns or "been on a diet11 to try to lose 
weight? (If Yes) At what age did you first diet? (Go to Question 3). (If No, go 
to Question 7). 
, 3{a) How many times in the last year (since Christmas 1993) ha-ve you changed your 
eating patterns or II dieted 11 to lose weight? (If izo diets in last year, go to Question 
7). . . -
3(b) During the last yeM, what was the longest and shortest length of time you spent 
on a diet(s)? • (Currently on a diet?) · 
4. During the diet(s), what types of c.hanges did you mnke to your eating patterns? 
(Specify frequency/amount/type of food or drink) 
I • 
I 
5 (a) When you were II dieting 11 , what was your goal weight? 
5(b) Did the changes result in any weight loss? (How much weight wst and for how 
wng?J 
Sc) ()~t, ~ ~ ~. ~tvf ~ def~ ta ~U~ 
&1t. t)lj{A_ ~ · {dt tf4 i /WJLf?) 
7. (If not currently dieting) Are there any particular worries or reasons which stop 
you from dieting? 
8. Have you ever seen a dietitian? (When/how often?). 
(If No), go tlJ Question 9. (If Yes), When was the last time you saw a 
dietitian? 
How helpful was this last appointment? (NOT/ilfODERATELYfVF,RY) 
... ., -. 
In what way was the last appointment unhelpful/moderately helpful/very helpful? • 
What changes to your eating patterns did the dietitian recommend? 
· Which of ~hese are you doing now? 
What has sfopped you from making the other changes ~hat were reeoi:nmended? 
Would it be helpful to see a dietitian again? 
YES/NO/PERHAPS/DON'T KNOW. If unhelpful, why? 
9. Do you think that having diabetes would affect a person's weight? YES/NO 
(If Yes) In what way? 
16. Are there any other ways you have tried to control weight, get rid of food you 
bad eaten, change your b~9-y's shape? (Exercise, pills, vomiting?) 
APPENDIXG 
CODING SYSTEM - DIABETIC PARTICIPANTS 
Diabetic participants 
Coding system 
• Years since diagnosis (number) 
• Main method of diabetes control 1 insulin 
2 tablets 
3 insulin + tablets 
4 diet only 
• Medical Problems 1 yes 
Ono 
thyroid, depression, other psychiatric illnesses, heart (eg: angina), 







• Number of times hospitalised for diabetes (number) 
• self SMOBG 1 yes 
Ono 
• how many times in last week (number) 
• machine meter (1) or strips against a bottle (0) or both (2) 
• lowest weight (since 18 years old) (kg) 
• highest weight (since 18 years old) (kg) 
• range of weight change (since 18 years old) (kg) 
• satisfied with current weight and body shape 
• concerns with current weight and body shape 
• decrease weight 
• increase weight 
1 
0 
1 yes (very) 
2 (moderately) 
3 no (not) 
1 yes 
Ono 
• other concerns 0 health; 1 clothing; 2 bone structure; 3 others 
comments; 4 more toned/ shape concerns; 5 
more stable weight desired; 6 low self-esteem + 
confidence 
• ever dieted 1 yes 
Ono 
• age of first diet (years) 
• number of diets in the last year (number) 
• shortest time spent on a diet in the last year (weeks) 
• longest time spent on a diet in the last year (weeks) 
0 main change made to diet (in the last year) 
l eat less 
2 eat less fat 
3 less protein 
4 more balanced diet 
5 eats one meal per day 
6 decrease carbohydrate intake 
7 increase salads 
8 decrease sweet consumption 
9 increase carbohydrates 
10 regular meals 
• goal weight when dieting (kg) 0 Don't know 
• any change in weight - increase 1, decrease 0, don't know 2, or 
same 3 
• how much (kg) 
• other changes 
• weight change maintained 1 yes O no 
• approximately how long for (weeks) 
• weight different to last year 
• Were blood sugars low on a diet? 
• How did you know? 










1 increase sugar, 2 nothing (good level), 3 monitor more closely 
• Worry that blood sugars may go too low on diet? 1 yes 
Ono 
• Does this effect dieting approach? 1 yes 
Ono 
• action taken 
1 increase carbohydrates and snacks between meals 
2 monitor food intake 
3 eat sensibly and monitor glucose levels 
4 don't diet 
Non-dieters (in last year) 
• Reasons for not dieting 
Specific reasons 
• not needed 





1 not happy when dieting; 2 miss foods; 3 body change, illness; 4 if 
unwell, 5 periods irregular and decreases energy; 6 
pointless/frustrating; 7 lack of willpower; 8 low blood sugars; 9 
damages health; 10 financial constraint, 11 diabetes, 12 self-
defeating, 13 worry if I don't stay on it, 14 family commitments, 15 
lifestyle (eg: too busy), 16 boring, 17 mood decreases - eat more, 
increased pressure, 18 added pressure. 











increases it 1 
decreases it 0 
2 big/ overweight people; 4 obesity/ overweight = risk factor; 5 get 'fat 
or thin'; 6 lifestyle and eating changes; 7 causes weight fluctuations; 
8 they are small people, 9 forced to eat if low sugars, 10 harder to 
loose the weight, 11 has maintained my weight, 12 determined by 
attitude to food and lifestyle, 13 metabolism slowed up, 14 increased 
appetite, 15 need to lose it for diabetes management. 
• Recommended dose of insulin/ tablets 
• Always take recommended dose 1 yes 
• How change 
Ono 
-increase (1) or decrease (0) 
• other - 1 increase/ decrease according to blood sugars and exercise, 
2 i/d according to what eaten, 3 forgets/confused/busy/can't be 
bothered, 4 if away, 5 if had alcohol, 6 can't afford to, 7 doctors 
advise 
• medication affect weight 1 yes 
Ono 
2DK 
• increase (1) or decrease (0) or (2) both - increase insulin and decrease 
tablets. 
• Have you ever thought about altering medication dose to change weight 
etc. 
1 yes Ono 
1 increase O decrease 2 both 
• ever done it? 1 yes 
Ono 
• action 
• tell doctor? 
1 increase, 0 decrease, 2 both 
I yes 
Ono 
• why not alter 1 complications unattractive 
• Have you altered your medication in the last month to change your 
shape/ weight? 
• How many times? 
• By what amount? 
1 yes Ono 
(number) 
(number) 
• other weight control methods ever tried 









CODING SYSTEM - CONTROL PARTICIPANTS 





thyroid, depression, other psychiatric illnesses, heart (eg: angina), 






• lowest weight (since 18 years old) (kg) 
• highest weight (since 18 years old) (kg) 
• range of weight change (since 18 years old) (kg) 
• satisfied with current weight and body shape 
• concerns with current weight and body shape 
• decrease weight 
• increase weight 
1 
0 
1 yes (very) 
2 moderately 
3 no (not) 
1 yes 
Ono 
• other concerns 0 health; 1 clothing; 2 bone structure; 3 others 
comments; 4 more toned/ shape concerns 
• ever dieted 1 yes 
Ono 
• age of first diet (years) 
• number of diets in the last year (number) 
• shortest time spent on a diet in the last year (weeks) 
• longest time spent on a diet in the last year (weeks) 
• main change made to diet (in the last year) 
1 eat less 
2 eat less fat 
3 less protein 
4 more balanced diet 
5 eats one meal per day 
6 decrease carbohydrate intake 
• goal weight when dieting (kg) 0 Don't Know 
• any change in weight 
• maintained weight loss 
• for how long (weeks) 
• weight different to last year 
• increased 
decreased 
Non-dieters (in last year) 
• Reasons for not dieting 
Specific reasons 
• not needed 

















1 not happy when dieting; 2 miss foods; 3 body change, illness; 4 if 
unwell, 5 periods irregular and decreases energy; 6 
pointless/frustrating; 7 lack of willpower; 8 low blood sugars; 9 
damages health; 10 :Cmancial constraints. 






• does diabetes affect a persons weight 
• increases it 
• decreases it 






2 big/ overweight people; 4 obesity/ overweight = risk factor; 5 get 'fat 
or thin'; 6 lifestyle and eating changes; 7 causes weight fluctuations; 
8 they are small people. 
• other weight control methods ever tried 














4 Back problems 
1 Raynards disease 
Diabetic participants 
Other medical problems 
1 Muscular dystrophy 




1 Irritable bowel syndrome 
1 Bowel hernia 
1 Hiatus hernia 
1 Priniceous anaemia 
1 Bronchitis 
1 Fluid retention 
2 Stroke 







1 Multiple Sclerosis 
1 Psoriasis 
APPENDIX J 
OTHER MEDICAL PROBLEMS -
CONTROL PARTICIPANTS 
1 Hearing problem 
1 Sinus problem 
1 'Nutcracker gullet' 
2 Minniers disease 
1 Back problem 
Control participants 
Other medical problems 
3 Arthritis or Rheumatoid Arthritis 
2 Kidney reflux 
1 ME 
1 Hayfever 
1 Degenerative cervical spine 
1 Migraine headaches 
1 Hiatus hernia 
1 Factor-7 bleeding disorder 
1 Stomach ulcer 
1 Perforated eardrum 
APPENDIXK 
OTHER PSYCHIATRIC ILLNESSES -
DIABETIC PARTICIPANTS 
1 anxiety 
1 bipolar disorder 
1 panic attack's 
Diabetic participants 
Other psychiatric illnesses 
